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ABSTRACT 
Chapter 1 provides an overview on the chemistry of pyridines and aminopyridines, their 
biological activities and their synthesis using Bohlmann-Rahtz, Hantzsch and 
Chichibabin methodology. It discusses the application of modern alternative reaction 
platforms, such as microwave-assisted synthesis and flow chemistry, of relevance to the 
synthesis and reactions of pyridine derivatrives.   
Chapter 2 discusses Lewis acid catalysis in the Bohlmann-Rahtz pyridine synthesis and 
describes new one-pot, two- and three-component methodologies that have been 
developed for the synthesis of natural products containing the pyridine motif. These 
methods have been compared and contrasted and applied to the use of tetranuclear 
coordination clusters as Lewis acid mixed metal catalysts for Bohlmann-Rahtz 
cyclodehydration and pyridine synthesis.  
Chapter 3 discusses the use of the Bohlman–Rahtz pyridine synthesis for the preparation 
of a range of fused heterocycles containing the pyridine moiety in high yield, including 
1,3,7-trimethylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione, 1,3-dimethyl-7-
phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione, 1,7-dimethylpyrido[2,3-
d]pyrimidine-2,4(1H,3H)dione and 1-methyl-7-phenylpyrido[2,3-d]pyrimidine-
2,4(1H,3H)-dione.  
 
Chapter 4 describes new substrate scope for the Bohlmann-Rahtz pyridine synthesis by 
incorporating an amino group at the 2-position of the products. The synthesis of a range 
of 2,3,6-trisubstituted and 2,3,4,6-tetrasubstituted pyridines was accomplished with total 
regiocontrol using this new method under microwave-assisted conditions. 
V 
 
Chapter 5 describes a new microwave-assisted method for the synthesis of poly-
deuterated pyridines. The microwave mediated deuteration of aminopyridine derivatives 
both with and without the presence of DCl has been studied. The regioselectivity and 
yields for these processes were compared. Following discovery of a new method for 
single cycle H/D exchange at multiple positions, high yield and high levels of deuterium 
incorporation have been found for a range of substrates. 
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CHAPTER ONE 
Introduction 
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1.   Introduction. 
1.1. Pyridines and their biological activity.  
The chemistry of pyridine, as we understand it today, could be attributed in part to a 
number of discoveries made in the latter half of the 19th century. Thomas Anderson 
isolated the first pyridine base, picoline, in 1846 from bone oil.1 In 1869 the chemistry of 
pyridine started to be rationalized when Wilhelm Körner and James Dewar (1871) 
independently formulated a mono-aza-analogue of benzene.2 Following structural 
understanding a number of synthetic processes were developed, starting with Baeyer who 
reported the synthesis of 2-picoline (2), albeit in low yield,3,4 from the reaction of acrolein 
(1) with aqueous ammonia (Scheme 1). 
 
 
Scheme 1: Synthesis of 2-picoline (2) from acrolein (1) and ammonia. 
 
In 1876 Ramsey discovered the original laboratory synthesis of pyridine (3).5 Reacting a 
mixture of acetylene and hydrogen cyanide in a red-hot tube gave the parent heterocycle 
(3) (Scheme 2),5 although large quantities of pyridine were more reliably obtained from 
natural sources via coal tar distillation. 
 
 
Scheme 2: Synthesis of pyridine (3) from acetylene and HCN. 
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Koehn and Elvehjem were able to isolate nicotinamide (4) and nicotinic acid (5) from 
vitamin B2 in the 1930s (Figure 1).6 Their discovery provided a new treatment for human 
pellagra, a vitamin deficiency causing dermatitis and dementia. From that date, 
researchers started to pay closer attention to the synthesis and properties of pyridine 
derivatives. 
 
Figure 1: Structures of nicotinamide (4) and nicotinic acid (5). 
 
The chemistry of pyridine provided fundamental understanding of the chemistry and 
properties of biological systems, since this heterocycle plays an important role in both 
biological and chemical coordination. The pyridine ring system is one of the most 
common heterocyclic motifs that is found to modulate the enzymes of living organisms. 
For example, nicotinamide adenine dinucleotide phosphate, NADP+ (6) (Figure 2), is 
intimately involved in various oxidation–reduction processes in biology.7  
 
 
 
Figure 2: Structure of nicotinamide adenine dinucleotide phosphate, NADP+ (6). 
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The pyridine moiety can be found in over 7000 pharmaceutical drugs such as the anti-
tuberculosis drug (7), the HIV inhibitor L-754,394 (8), agrochemicals (911) (Figure 3)8 
and a large number of natural products.911 
 
 
 
 Figure 3: Structures of some pyridine containing pharmaceutical drugs and      
agrochemicals. 
 
The presence of the pyridine motif in a wide range of molecules make it a very important 
heterocyclic class in chemistry. In modern pharmaceuticals the motif is very common, 
with over one hundred currently marketed drugs containing this vital unit.12  
The pyridine motif is common in nature and is present in a number of biologically active 
natural products. In biological systems the potency of pyridines is well demonstrated by 
the essential vitamins niacin (5) (vitamin B3) and pyridoxine (12) (vitamin B6) as well as 
the toxic alkaloid nicotine (13) (Figure 4).13 
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Figure 4: The pyridine motif is present in a number of biologically active molecules. 
As well as natural products, the pyridine structure is commonly found in pharmaceutical 
agents. Sulfapyridine (14) was one of the first antibiotics, used to treat Winston 
Churchill’s bacterial pneumonia in 1942. Currently marketed drugs containing the 
pyridine unit include the blockbuster drugs Omeprazole (15) (Nexium)® and loratadine 
(16) (Claritin)® (Figure 5).12 
 
Figure 5: The pyridine structure is found in pharmaceutical agents. 
Pyridines have also found applications as ligands in organic and inorganic chemistry. 
2,2’-Bipyridine (bipy) is a bidentate chelating ligand that is used in the rhenium catalyzed 
reduction of carbon dioxide.14 Additionally, bipy has been incorporated into metal 
organic frameworks as a heterogenous catalyst for the epoxidation of alkenes.15 In 
synthetic organic chemistry, with potential for biological applications, pyridines have 
found use as nucleophilic catalysts in organic transformations. For example,  
4-dimethylaminopyridine (DMAP) (17) has been widely used in a range of 
transformations including acylation and esterification reactions.16,17 
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With this wide range of applications, methods for pyridine synthesis are an ever-present 
focus of new research, with reviews even focusing on the most recent advances in the 
synthesis of pyridine derivatives.18 
 
1.2. Aminopyridines and their biological activity. 
 
There is a wide array of different substituents and possible substitution patterns of 
pyridine derivatives and of these, 2-aminopyridines have featured prominently in recent 
times as they have been incorporated into new cancer treatments.19 Amongst many other 
applications, 2-aminopyridines are important as nitric oxide synthase inhibitors,20 
intermediates in the industrial synthesis of zolpidem (Ambien)®,21 and also as ligands in 
organic and inorganic chemistry.22 Aminopyridines are important compounds 
biologically, able to elicit a wide range of biological responses in a number of different 
organisms. Sulfapyridine (14) was one of the first effective antibiotics but their 
therapeutic application is just as relevant today.23 4-Aminopyridine (Fampridine) has 
been used for the symptomatic treatment of multiple sclerosis.24 Furthermore, a  
2-aminopyridine has recently been approved as a new anaplastic lymphoma kinase (ALK) 
inhibitor (18) for treatment of non-small cell lung cancer (Figure 6).19 
 
 
  Figure 6: 2-Aminopyridines are important in the pharmaceutical industry. 
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  1.3. Pyridines and their synthesis. 
Synthetic approaches towards pyridine derivatives generally adopt one of two strategies: 
the functionalization of a pre-formed pyridine unit bearing appropriate substituents or 
the synthesis of the pyridine ring. The latter of these two approaches is often the more 
challenging, although there are many ways of achieving the synthesis of a pyridine ring. 
Perhaps one of the most predictable is the reaction of ammonia with a 1,5-dicarbonyl 
compound to give 1,4-dihydropyridines, which are easily dehydrogenated to give the 
corresponding pyridines (Scheme 3).25 With unsaturated 1,5-dicarbonyl compounds, or 
their equivalents for example pyrylium ions, ammonia reacts to give the pyridine 
product directly (Scheme 4).25 
 
Scheme 3: Synthesis of 1,4-dihydropyridines from 1,5-dicarbonyl compounds. 
 
 
Scheme 4: Synthesis of pyridines directly from 1,5-dicarbonyl compounds, or their 
equivalents. 
These are examples of [5+1] approaches to pyridine synthesis. Although often high  
yielding and able to tolerate a wide range of substituents, these methods require efficient 
access to the 1,5-dicarbonyl component, which is usually not readily accessible. As a 
result many more direct approaches have been explored using multiple component 
reactions.  
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There are two well-known [2+2+1+1]-routes for pyridine synthesis using 4-component 
processes, as potentially more convergent and direct approaches: the Hantzsch-type and 
Chichiabin-type cyclocondensation reactions. 
 
 
1.3.1. The Hantzsch Dihydropyridine Synthesis [2+2+1+1]. 
 
The Hantzsch dihydropyridine (DHP) synthesis is one of the most popular methods for 
the synthesis of pyridines. This classical method was first published by Hantzsch in 1882 
but it still remains highly relevant today.26 In the 1980s the 1,4-DHP products were found 
to be useful biologically active molecules, mainly as calcium channel antagonists.27,28 
There are at lest ten currently marketed pharmaceutical agents containing the 1,4-DHP 
motif, including felodipine (19) and amlodipine (20) (Figure 7), demonstrating the 
importance of these compounds for the treatment of hypertension.29, 30 
 
Figure 7: Two DHPs used clinically for the treatment of high blood pressure 
(hypertension). 
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The classical Hantzsch dihydropyridine synthesis is a well-known multi-component 
reaction that involves the cyclocondensation of an aldehyde, ketone (two molar 
equivalents) and ammonia or ammonium acetate.31 Since the original report, there have 
been many developments and applications in the literature. 
One such example of a Hantzsch-inspired strategy was reported by Hegde and co-workers 
in 1987 (Scheme 5), which required an aryl substituent at the pyridine 4-position for the 
synthesis of a tetrapyridine (21).32 
 
 
 
Scheme 5: An example of a [2+2+1+1] Hantzsch-strategy for the synthesis of a 
tetrapyridine (21). 
 
Another example, reported in 1970 by Alvarez-Insua and co-workers, used malononitrile 
22 as the reactive methylene component to create the pyridine 23 functionalized with 
electron-donating groups at C-2 and C-6 (Scheme 6).33 
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Scheme 6: An example of a [2+2+1+1] Hantzsch-strategy for the synthesis of pyridines 
bearing electron-donating groups.  
 
In 1998 Khmelnitsky and co-workers demonstrated the first practical application of 
microwave-assisted combinatorial synthesis (MICROCOS) in a Hantzsch pyridine 
synthesis (Scheme 7). Microwave-assisted organic synthesis (MAOS) can offer some 
interesting advantages over standard techniques, such as greatly reduced reaction times 
and solvent-free synthesis. A solution of the reactants (Scheme 7a) in a volatile solvent 
was impregnated into bentonite clay, the solvent was evaporated and the clay was 
irradiated by microwaves. Ammonium nitrate was also present as the source of ammonia 
and oxidant (nitric acid). The reactions were described as solution-phase as the reactants 
were non-covalently bound to a solid. This method was applicable to a range of ketones 
and aldehydes (Scheme 7b).34 
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Scheme 7:  (a) Solution-phase combinatorial strategies for the synthesis of substituted 
pyridines. (b) Selection of ketones and aldehydes used in a combinatorial approach. 
 
A number of different reagents have been reported for the efficient oxidation of Hantzsch 
DHP, including, but not limited to, nitric acid,36 ferric chloride,36 potassium 
permanganate36 and calcium hypochlorite.37 Even today, more than a century after the 
discovery of the Hantzsch DHP synthesis, research is on-going with regards to 
discovering greener alternatives as reagents to facilitate aromatization of the 1,4-DHP to 
provide the pyridine products.38 For example, in the Hantzsch DHP synthesis, 
formaldehyde, ethyl acetoacetate (24) and ammonium acetate were reacted in aqueous 
medium under reflux conditions to give dihydropyridine 25. Aromatization of 25 with 
FeCl3 gave the corresponding pyridine derivative 26 in 93% yield (Scheme 8).
31 
 
 
Scheme 8. Hantzsch dihydropyridine synthesis and subsequent aromatization. 
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The classical reaction is a three-component reaction between two equivalents of a  
1,3-dicarbonyl compound, ammonia and an aldehyde to generate the DHP, followed by 
an oxidation (or aromatization) step to yield the corresponding pyridine (Scheme 9).23 
 
Scheme 9: The classic Hantzsch dihydropyridine synthesis (R = aryl, alkyl). 
 
This method allows the synthesis of highly substituted pyridines on oxidation, however 
it is limited to symmetrical products. The synthesis of unsymmetrical 1,4-DHPs is an 
important modification of the classic Hantzsch method. Generating an enone separately 
in an aldol condensation, then reaction with an enamine can generate unsymmetrical 
DHPs, as demonstrated by the synthesis of felodipine (19) (Scheme 10).23 
 
 Scheme 10: The synthesis of unsymmetrical DHPs. 
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Although a valuable way to access pyridines, there are some drawbacks in the use of this 
methodology. The Hantzsch method is reasonably limited to carboxyl groups at the 3- 
and 5-positions, or other suitable electron-withdrawing groups, and aryl or alkyl groups, 
or other similar substituents at the 4-position.39 In order to access different substitution 
patterns and incorporate alternative substituents, different synthetic approaches are 
required.               
The optimum temperature seems to be 130 oC; the aromatization does not occur 
efficiently at lower temperatures and higher temperatures result in significant product 
decomposition (Scheme 11).40 
 
 
Scheme 11: Microwave-assisted Hantzsch pyridine synthesis.  
 
 
Highly substituted polyaryl pyridines (28), can also be obtained by Hantzsch-type 
methods using the combination of an aromatic ketone, an aldehyde and an ammonium 
salt under microwave irradiation at 150-170 oC in water.41 A similar reaction can be 
carried out in one pot using poly(ethylene glycol) (PEG) as medium (Scheme 12).42 
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Scheme 12: Synthesis of polyarylpyridines 28. 
 
Spontaneous oxidation in situ with DHP synthesis has also been achieved under 
microwave irradiation. Condensation of the keto and aldehyde components using 
ammonium nitrate/bentonite as both the nitrogen source and oxidant in the presence of a 
small quantity of dimethylformamide (for heat transfer) under microwave irradiation gave 
pyridines directly within 5 minutes. This procedure was used in microwave-assisted 
combinatorial chemistry for the generation of Hantzsch esters such as 29, in a solvent-
free medium (Scheme 13).43 
 
 
Scheme 13: Direct synthesis of a Hantzsch pyridine ester (29). 
 
Solvent-free conditions have also been utizized in a base-catalyzed Hantzsch-type 
cyclocondensation using 4-acetylpyridine (30). Both symmetrical (e.g. 31) and 
15 
 
unsymmetrical 2,6-diaryl-substituted pyridines were readily accessible via sequential 
solvent-free aldol condensation and Michael addition using solid sodium hydroxide, 
followed by treatment with ammonium acetate in acetic acid, as a one-pot reaction 
(Scheme 14).44,45                                                                                                                                                                           
 
Scheme 14: Synthesis of Hantzsch-type pyridines using solvent-free conditions. 
 
The mechanism for Hantzsch reaction involves initial Michael addition of an enamine 
(33) to an α,β-unsaturaturated ketone 24, which is generated by an aldol aondensation, 
followed by cyclodehydration to give the DHP 25 product (Scheme 15).  
 Evidence for this mechanism has been found by Katrizky in a closely related 
transformation by 13C NMR spectroscopy in which the rate-determining step was 
proposed to by the Michael addition on the basis of the species observed in the course of 
the reaction.46                                         
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Scheme 15. Suggested mechanism for Hantzsch dihydropyridine 25 synthesis. 
 
1.3.2. Chichibabin Pyridine Synthesis [2+2+1+1].       
 
In 1905, Chichibabin reported the thermal cyclocondensation between aldehydes, 
ketones, α,β-unsaturated carbonyl compounds or various derivatives of such 
compounds with ammonia or its derivatives to form substituted pyridines. This is one 
of the oldest studied organic reactions.47  
The mechanism for Chichibabin reaction involves initial aldol condensation, followed 
by condensation of a third component to form an imine by the reaction of aldehyde 
with ammonia Michael addition of this imine with the aldol condensation product 
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followed by cyclodehydration forms a dihydropyridine which, in turn, is 
dehydrogenated to the pyridine product (Scheme 16).48 
 
 
 
 
Scheme 16. Suggested mechanism for Chichibabin pyridine synthesis. 
 
Synthesis from Acryloyl Azides by Curtius Rearrangement. 
A number of modifications of the Chichibabin process have been described. A series of 
disubstituted pyridine derivatives (e.g. 32), have been synthesized from the corresponding 
acryloyl azides by acid promoted cycloaddition (Scheme 17).49 This represents a novel 
and convenient synthetic approach to symmetrical 3,5-disubstituted pyridines. The nature 
of the substituent on the double bond and the solvent used are crucial to give a reasonable 
yield of the pyridine product. The reactivity of the acid-promoted cycloaddition increases 
with the  presence of aryl groups, such as phenyl and pyridyl moieties. The reaction is a 
Chichibabin-type condensation, the mechanism of which was proposed on the basis of 
careful examination of the crude products and involves Curtius rearrangement followed 
by an addition-cycloaddition sequence.50 
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.Synthesis from Acetaldehydes and a Nitrogen Donor 
3,5-Diarylpyridines can also be formed though a cascade Chichibabin-type cyclization 
using different nitrogen sources. Ammonium cerium (IV) nitrate (Scheme 18a) and 
trimethylsilyl-azide (Scheme 18b) are efficient nitrogen donors in this copper-catalyzed 
reaction which provides complementary products depending upon the conditions. Water 
and molecular oxygen act as the oxygen source for benzylic oxidation of the C2 
substituent.51 
 
 
 
Scheme 18: Synthesis of pyridine derivatives from acetaldehydes and a nitrogen donor. 
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1.3.3. The Bohlmann-Rahtz Pyridine Synthesis [3+3]. 
 
One of the most popular recent methods for the synthesis of pyridines is the Bohlmann-
Rahtz pyridine synthesis. This method bears a number of similarities mechanistically to 
the Hantzsch DHP synthesis but accesses the pyridines directly without the need for a 
separate oxidation step. First outlined by Bohlmann and Rahtz in 1957, the method is 
efficient, totally regioselective and a two-component process that can generate  
2,3,6-trisubstituted or 2,3,4,6-tetrasubstituted pyridines directly.52 The original method 
reported the reaction of an enamine (33) and ethynyl ketone (34) and required two steps 
in order to access the target heterocycle. Firstly, Michael addition of the two components 
proceeded to provide an aminodiene intermediate (35), which was isolated and then 
heated at high temperature to facilitate E/Z isomerization and spontaneous 
cyclodehydration to yield the pyridine (36) (Scheme 19).53  
 
Scheme 19: The mechanism of the two-step Bohlmann-Rahtz pyridine synthesis. 
 
There are a number of other closely related [3+3]-based routes to pyridines, including 
variants of the Guareschi synthesis, in which a ketoester reacts with triethyl orthoformate 
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to give an ester enol ether (37), before Michael addition of a 3-aminoacrylonitrile (38), 
as reported by Henecke in 1949 (Scheme 20).54  
 
Scheme 20: Alternative [3+3]-route to highly-substituted pyridines. 
 
More unusual still in a related [3+3]-approach is the cyclization of an enone and 
iminophosphorane, prepared from the corresponding benzotriazole-substituted precursor 
developed by Katritzky and co-workers (Scheme 21).39,55 The reaction course depends 
upon substrate and in this case seems to involve Michael addition followed by proton 
transfer and then aza-wittig reaction to give a dihydropyridine, which is readily oxidized 
to the product.55 
 
Scheme 21: [3+3]-synthesis of pyridines using a (vinylimino)phosphorane. 
Since the discovery of the Bohlmann-Rahtz reaction, this highly regioselective and 
reasonably versatile pyridine synthesis was largely neglected for a number of years save 
for a few isolated reports by Baldwin et al. on the synthesis of heterocyclic amino  
acids,56, 57 until its use in the first total synthesis of the thiopeptide antibiotic promothiocin 
A (40).58 The 2,3,6-trisubstituted pyridine core (39) of this antibiotic was synthesized by 
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the Bohlmann-Rahtz method by Bagley and Moody, followed by 11 steps to reach the 
final product 40 (Scheme 22). 
 
 
Scheme 22: The total synthesis of promothiocin A using the Bohlmann-Rahtz pyridine 
synthesis. 
Although very efficient and providing access to highly-substituted products, a  Bohlman-
Rahtz approach does involve a number of distinct steps. This versatile, but little used, 
route to pyridines, forms a fully unsaturated pyridine directly and was demonstrated by 
Moody and co-workers in 2003 in the synthesis of pyridine libraries (Scheme 23) using 
the original conditions.59 
 
Scheme 23: An example of [3+3] pyridine synthesis using the Bohlman-Rahtz method. 
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The application of this method in the total synthesis of thiopeptide antibiotics resulted in 
research into how this neglected synthesis could be improved. A report by Bagley in 2001 
described efforts to lower the reaction temperature, and incorporate the use of acid 
catalysts into the process.60 The aminodiene intermediate 35 was prepared according to 
the initially reported conditions52 and then stirred in a toluene/acetic acid mixture at 50 °C 
for 6 hours forming pyridine 36 in quantitative yield, without the need for further 
purification (Scheme 24). This example demonstrated a dramatic reduction in the 
temperature necessary for E/Z-isomerization, compared with the high temperatures (120-
150 °C) that were previously required for the same transformation. 
 
Scheme 24: Heating in a toluene/acetic acid mixture dramatically reduced the reaction 
temperature required to facilitate pyridine formation. 
Microwave-assisted conditions can reduce the reaction times of organic transformations, 
compared to conventional heating methods, particularly when using laboratory-designed 
closed vessel reactors. In 2002, the Bagley group attempted to improve the methodology 
of the Bohlmann-Rahtz pyridine synthesis by employing microwave-assisted 
conditions.61 In doing so they discovered that the Bohlmann-Rahtz pyridine synthesis 
could take place in one-step with total regiocontrol. Reaction between ethynyl ketone 41 
and enamine 33 proceeded in 10 min in toluene/acetic acid (5:1) at a temperature of 
170 °C, to form pyridine 42 in 98% yield (Scheme 25). This was the first report of the 
Bohlmann-Rahtz pyridine synthesis proceeding in one-step under microwave irradiation 
and indicated the huge potential of this method of pyridine synthesis. 
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Scheme 25: Microwave-assisted heating reduced the reaction time of the Bohlmann-
Rahtz pyridine synthesis and proceeded in a single step. 
 
In 2010, Kantevari et al. reported the cerium(III)-catalyzed facile synthesis of 
dihydrobenzofuran-tethered pyridines and dihydroquinolin-5(6H)-ones from  
β-enaminones in a variant of the Bohlmann–Rahtz reaction. Inspired by the Bagley multi-
component process,62 they hypothesized that β-enaminones could serve as Bohlmann–
Rahtz variants of ethynyl ketones in the synthesis of 2,3,6-trisubstituted pyridines. Given 
that cerium(III) chloride had emerged as an inexpensive, efficient, and green reagent for 
this transformation, they reported that CeCl3·7H2O–NaI catalyzed the regioselective 
conversion of dihydrobenzofuranyl-substituted enaminones 43a,b into novel substituted 
pyridines 44 and dihydroquinolin-5(6H)-ones tethered with a dihydrobenzofuran group 
through a Michael addition / cyclodehydration sequence in a one-pot process (Scheme 
26).62 
 
Scheme 26: One-pot synthesis of pyridine 44. 
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Kantevari also utilized this variant of the Bohlmann-Rahtz reaction in a facile synthesis 
of novel acyclo-C-nucleoside analogues from L-rhamnose. Analogues bearing substituted 
pyridines 48, dihydro-6H-quinolin-5-ones, dihydro-5H-cyclopentapyridin-5-one, 
tetrahydrocyclohepta[b] pyridine-5-one, and azafluorinone were generated in very good 
yields, using the CeCl3·7H2O-NaI-catalyzed one-pot cyclocondensation of the 
corresponding β-enaminones 47 derived from L-rhamnose (45), 1,3-dicarbonyl 
compound 46, and ammonium acetate (Scheme 27).63 
 
 
  
Scheme 27: Synthesis of pyridine 48. 
 
In 2007 Danielle reported a new enantioselective synthesis of monofluorinated pyridines; 
he found that pyridines with a fluorine atom in the benzylic position were easily 
accessible from optically active propargylic fluorides by using the Bohlmann–Rahtz 
reaction. Such pyridines, possessing four points of molecular diversity, could be useful 
scaffolds for the preparation of chemical libraries and the design of new strategies for the 
enantioselective synthesis of monofluorinated molecules.64 Using the Bohlman–Rahtz 
reaction,52 under the conditions described by Bagley,65 and the key intermediates, 
optically active propargylic fluorides such as 49 as shown (Scheme 28), gave the desired 
pyridine 50 in 71% yield. This study confirmed the versatility of propargylic fluorides in 
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the synthesis of useful building blocks for further applications in organic and medicinal 
chemistry. These fluorides were easily accessible in high enantiomeric purity and the 
Bohlmann–Rahtz reaction afforded, under the conditions proposed by Bagley, interesting 
pyridines with several points of molecular diversity.66 
 
 
Scheme 28: Synthesis of pyridine 50. 
 
In 2011 Srinivas Kantevari used related reaction conditions to synthesize pyridine 
derivatives using a Bohlmann-Rahtz variant as a novel one-pot reaction, by reacting   
β-enaminones 47 with ethyl acetoacetate (51), and ammonium acetate in the presence of 
CeCl3.7H2O-NaI in 2-propanol at reflux temperature which in 4 h, gave the product 36 in 
85% yield (Scheme 29).67 
 
 
Scheme 29: Synthesis of pyridine 36 in a one-pot reaction. 
 
Aulakh and Ciufolini in 2009 reported Bohlmann-Rahtz reactions using modified 
conditions based on the use of a 5:1 mixture of toluene and acetic acid as the solvent. The 
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reaction of ammonium acetate and 1,3-cylohexanedione (52) or acetoacetate 51 with 
ketone 41 and NH4OAc in progressively more acidic conditions indicated that the reaction 
was best carried out in refluxing acetic acid (Scheme 30).68 The reaction of  
1,3-cyclohexanedione (52) also gave rise to 5-benzoyl-2-phenylpyridine (53) as a side 
product from Bohlmann-Rahtz dimerization of ketone 41.  
 
 
Scheme 30: Synthesis of pyridines in one-pot Bohlmann-Rahtz reactions. 
 
Recently, the one-pot 3-component cyclocondensation of a ketone, ethynyl ketone and 
ammonia has been named by Müller and Dohe as the Bagley-Bohlmann-Rahtz (BBR) 
pyridine synthesis,69 and has been extended to a three-component or four-component 
coupling by incorporating a modified Sonogashira alkynone synthesis into a sequential 
one-pot process. Although the yields for this transformation were modest at best, it was 
successful for the preparation of 15 differently substituted 3-ethoxycarbonyl-2-methyl 
pyridines by sequential 3-component Bagley-Bohlmann-Rahtz reaction, revealing the 
potential of this methodology in heterocycle synthesis (Scheme 31). 
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Scheme 31: 3-Component Bagley-Bohlmann-Rahtz synthesis with modified Sonogashira 
ethynyl ketone preparation.  
 
These examples expanded the available substrate scope of the Bohlmann-Rahtz pyridine 
synthesis and provided new simpler and faster methodology for carrying out this process, 
that could be used to access pyridine-containing natural products such as the thiopeptide 
antibiotics. The temperature and reaction times required for this transformation have been 
reduced by these modified methods, all the while maintaining total regiocontrol. It is clear 
from these examples and from reviews on this process,70 however, that the substrate scope 
remains limited to date at the 3-position to carboxylate derivatives or electron poor 
heterocycles, and at the 2-position of the pyridine targets to alkyl, aryl or heteroaryl 
groups and this restricts its application. If this scope could be expanded to incorporate 
amino groups, this would provide an alternative to the Chichibabin process (see 1.4. 
below) and thus access frameworks that may be more applicable to drug discovery 
programmes.  
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1.4. Aminopyridines and their Synthesis. 
The Chichibabin reaction as it is known, distinct from the [2+2+1+2] Chichibabin 
pyridine synthesis, involves reaction of pyridine with sodium amide to form  
2-aminopyridines (Scheme 32).23 It is an unusual reaction in that hydride acts as a leaving 
group during the course of the reaction. 
 
Scheme 32: The Chichibabin amination. 
 
The classical Chichibabin (or Tschitschibabin) amination is the 2-amination of pyridine 
and has been extended to simple derivatives, for example the amination of  
2,3-dimethylpyridine (54) (Scheme 33).71,72 Generally, the amination of pyridines 
substituted with electron-withdrawing groups may give products which stem from a ring-
opening reaction.73 
 
Scheme 33: Tschitschibabin reaction of 2,3-dimethylpyridine. 
 
In a related process nitropyridine 55 can be directly aminated with  
O-methylhydroxylamine in the presence of zinc(II) chloride under basic conditions to 
give 56 in high yield (Scheme 34).74 This zinc-promoted amination is a “vicarious 
nucleophilic substitution” process and high ortho selectivity with respect to the nitro 
group is observed. 
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Scheme 34: Amination of nitropyridine. 
 
Thus although there are methods available for the direct 2-amination of pyridines they 
require forcing conditions and suffer from limited substrate scope and so new methods 
for the synthesis of these targets are required. 
 
1.5.  Application of alternative reaction platforms. 
1.5.1. Microwave-Assisted Synthesis. 
Over the past two and a half decades, microwave-assisted synthesis has been recognized 
within mainstream organic chemistry as a clean and efficient way of achieving fast, high-
yielding transformations.75 The initial adoption of microwave-assisted methods in organic 
synthesis was perturbed due to issues with safety, controllability and poor understanding 
of the mechanics of dielectric heating. However, since the development of new 
instruments offering a greater degree of control, microwave-assisted synthesis has 
emerged as one of the most convenient and practical methods of expanding reaction 
ranges in industry and academia.76 Microwave heating in sealed vessels can dramatically 
increase the temperature of the solvent above its boiling point and therefore increase the 
rate of reaction in line with the Arrhenius law (Equation 1).77 
                         
                                                                                             
                                                                                            [Equation 1]  
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 An example of a reaction that demonstrates the Arrhenius relationship is the 
cyclocondensation of 1,2-diaminobenzene (57) and acetic acid to form benzimidazole 
(58) (Scheme 35).78 This reaction takes 9 weeks to reach completion at room temperature, 
5 hours at 100 °C under conventional heating and 1 second under microwave-conditions 
in a sealed vessel at 270 °C. The ability of the solvent to become ‘super-heated’ above its 
boiling temperature is a huge advantage to the organic chemist as a means to reduce 
reaction times and thus increase productivity. 
 
 
Scheme 35: Temperature of the reaction mixture has a dramatic effect on reaction times 
for the cyclocondensation of diamine 57 and acetic acid. 
 
Dielectric heating using microwave synthesizers takes advantage of two heating 
mechanisms endowed by the electric field element of electromagnetic radiation. When a 
polar molecule is subjected to an oscillating external electric field, dipolar polarization 
occurs and the molecule rotates as it attempts to align with the undulating field. 
The frequency of radiation determines how quickly the molecule rotates; however, if the 
frequency is too high then the molecule does not have enough time to adjust and rotate, 
and will remain stationary. The energy window of microwave irradiation lies at a 
frequency that is low enough to allow the polar molecules to rotate and try to align with 
the field, but not too high for them to align fully before the phase of the wave has changed, 
creating a phase difference. This phase difference results in friction and collisions 
between molecules in solution, and loss of energy from the molecules as heat. 
31 
 
The addition of ions to solution can greatly increase the rapidity of heating through an 
alternative conduction mechanism. Ions will rapidly align with the oscillating electric 
field and travel swiftly through the solution to collide with other molecules and convert 
kinetic energy into heat energy. As collisions between molecules are essential, microwave 
dielectric heating is not possible in the gas phase.79,80 Through a combination of these 
mechanisms, rapid temperature gradients can be achieved, and, through the use of sealed 
vessels, solvents can be heated above their atmospheric boiling point, creating energy 
profiles which are challenging to achieve by conventional means. These gradients can 
even create new selectivity profiles for reactions. For instance, reaction conditions can be 
tailored to favour the thermodynamic product of a regioselective reaction over the kinetic; 
by increasing the power of the microwaves the rate of heating is vastly increased, 
favouring a thermodynamic transformation.77,78 This technology has been applied in a 
wide range of different fields in synthetic chemistry, including drug discovery,81 polymer 
chemistry,82 and the synthesis of colloidal inorganic nanocrystals,83 amongst others. 
1.5.2. Flow chemistry platforms. 
 
 
In recent years some of the advantages, in terms of sealed vessel technology and rapid 
reaction kinetics, associated with microwave-assisted synthesis have been delivered by 
flow chemistry platforms. Given the limited penetration depth of microwave irradiation 
through an organic medium, continuous flow processing offers a means to scale up 
microwave-assisted reactions using conductive heating carried out in a flow cell at high 
temperature and pressure under the action of a back-pressure regulator. Flow chemistry 
platforms offer a number of advantages over batch processing methods, including small 
chemical inventories of reaction species, excellent temperature control and heat-to-mass 
transfer, predictable mixing, ready automation and in-line monitoring. Furthermore, a 
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number of different commercial instruments are available, minimizing the difficulties in 
transferring processes to continuous production. 
A number of methods for pyridine synthesis have been transferred to continuous 
processing platforms. In 2013 Rainer and Robert reported the kondrat’eva reaction in 
flow to provide direct access to annulated pyridines. A continuous flow inverse-electron-
demand Kondrat’eva reaction was developed that provided direct access to 
cycloalka[c]pyridines from unactivated oxazoles and cycloalkenes in a one-step process 
under harsh conditions, as valuable scaffolds for medicinal chemistry (Scheme 36).84 The 
flow synthesis of annulated 5-aryl-substituted pyridines by a similar process, a tandem 
intramolecular inverse-electron-demand hetero-/retro-Diels–Alder reaction, has been 
reported using continuous flow processing in good to excellent yields.85 
 
 
 
 
 
Scheme 36: Flow synthesis of pyridines. 
 
 
A flow microreactor method for the synthesis of disubstituted pyridines by generation of 
pyridyllithiums followed by reactions with electrophiles has been reported by Yoshida et 
al. By using a short residence time and efficient temperature control, the cryogenic 
conditions required for conventional batch macro processes were avoided and sequential 
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reaction of two different electrophiles with dibromopyridines was possible using an 
integrated flow microreactor system (Scheme 37).86 
 
 
 
Scheme 37: An integrated flow microreactor system for sequential introduction of two 
electrophiles into dibromopyridines. 
 
In a related process the flow synthesis of  a series of 2-methylpyridines via α-methylation 
has been reported using a simplified bench-top continuous flow setup and a column 
packed with Raney® nickel using a low boiling point alcohol (1-propanol) at high 
temperature (>180 oC) to give 2-methylpyridines with high selectivity and excellent 
yield.87 
 
An assortment of processes for the synthesis and reaction of pyridine derivatives have 
been described under flow conditions. Recently a continuous-flow microfluidic reactor 
for C-O bond formation in electron-deficient pyridines has been reported giving a cleaner 
reaction profile, high yield, quick scalability, and without the need for a transition metal 
catalyst.88 A two step micro continuous flow assembly has been used to form polypyridine 
derivatives in excellent purity and yield by reaction of propargylamine with  
bis-α-H-methylketones over montmorillonite K-10 and gold nanoparticle impregnated 
alumina in a packed bed capillary reactor at reaction temperatures of 120–140 °C and 
residence times of 10 min.89 In 2011 Martin reported the synthesis of annulated pyridines 
by intramolecular inverse-electron-demand hetero-Diels–Alder reaction under 
superheated continuous flow conditions. The superheating of organic solvents far beyond 
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their boiling point enables toxic and difficult to workup solvents such as nitrobenzene or 
chlorobenzene, which are usually employed for these reactions, to be replaced by less 
harmful ones like toluene. The relative rate of reactivity for a series of structurally close 
starting materials was investigated and a scalable flow process was developed, providing 
facile access to a series of novel annulated pyridine building blocks.90 
 
1.6. Goals of this Project. 
Given the value of pyridine derivatives in biology, agrochemistry synthesis and drug 
discovery, and the huge potential of the Bohlmann-Rahtz method, as an efficient, 
predicable and totally regioselective [3+3] method, this project aimed to expand the 
utility, application and scope of this synthetic method and apply it to a new arena. 
Aminopyridines are valuable targets in medicinal chemistry, hitherto inaccessible by  
Bohlmann-Rahtz methods. To that end, the goals of this project were:- 
1- Develop more efficient catalytic methods for carrying out the Bohlmann-Rahtz 
process that could proceed with lower catalyst loadings. 
2- Apply these methods to the hitherto-unreported Bohlmann-Rahtz synthesis of 
aminopyridines. 
3- Explore the H/D exchange reaction of aminopyridines as a means to study the 
pharmacokinetic properties of aminopyridine containing drugs. 
The outcome of these studies would then be new technology for the synthesis of pyridine 
derivatives, new diversity in the compounds that could be accessed by such methods and 
new understanding of methods used to elucidate their biological properties. 
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CHAPTER TWO 
New methods for acid-catalyzed Bohlmann-Rahtz reaction 
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2. New methods for acid-catalyzed Bohlmann-Rahtz reaction. 
Acid catalysis features in many processes in organic chemistry. Many acids can act as a 
proton donor to accelerate chemical reactions, changing the energy of intermediate 
species and the transition states involved or promoting the capability of leaving groups to 
convert one species into other compound classes.91 The Bohlmann–Rahtz reaction 
requires a Michael donor (enamine) and a Michael acceptor (ethynyl ketone). It has been 
shown that the use of a Brønsted (acetic acid) or Lewis acid promotes the conjugate 
addition and subsequent double bond isomerization necessary for spontaneous 
cyclodehydration to the pyridine product, to provide a one-pot method for the synthesis 
of pyridines. Furthermore the presence of an acid enables the reaction to proceed at a 
lower temperature than the original Bohlmann–Rahtz conditions, by formation of a 
protonated intermediate, and avoids the need to isolate the conjugate addition product. 
In recent years, the use of microwave dielectric heating in synthetic chemistry has seen 
widespread application.92 Microwave–assisted organic synthesis (MAOS) benefits from 
no direct contact between the chemical reactants and the energy source. It can provide 
very fast heating rates and is readily automated using commercial instruments, leading to 
singnificant improvements in efficiency. Most of the available systems for organic 
synthesis focus microwaves in a monomodal cavity, leading to enhanced temperature 
control, safer operation, reproducible methodology and widespread uptake by academia 
and industry.93 
Modern monomodal instruments dedicated for MAOS are very successful in small scale 
batch operations, but efforts to process this technology on a larger scale, for example in 
continuous flow (CF) reactors, are frustrated by the physical limitations of microwave 
heating, The Bohlmann–Rahtz pyridine synthesis has been used as a model 
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transformation for exploring the capability of a microwave flow reactor as well as to 
compare related conductive heating platforms and the transfer of reaction parameters 
between different technologies.94 The development of a microwave-assisted CF process 
(Figure 8) for the synthesis of pyridines based upon the Bohlmann-Rahtz reaction has 
been examined in a bespoke microwave flow cell.95 Aminodienone 35 was subjected to 
cyclodehydration in a CF process under homogeneous conditions in a mixture of toluene-
acetic acid (5:1 by volume) over sand as a medium. The results were compared with batch 
experiments that were carried out in a sealed tube under microwave irradiation and a 
homogeneous CF process using a commercially available Teflon heating coil (Scheme 
38).95 Under these conditions, acetic acid acted as a homogenous acid catalyst, 
accelerating the process to provide an excellent yield of the pyridine product. 
Furthermore, the short reaction times enabled the ready transfer of this process to a CF 
reactor that could operate under relatively fast flow rates for continuous production.  
 
 
Figure 8: Schematic diagram of the CF microwave reactor.53 
 
 
Drilled porous frit
Drilled porous frit
Steel head
outflowinflow
10 mL glass 
pressure tube
IR sensor
Sand
MW MW
38 
 
 
 
Scheme 38: Microwave-assisted Bohlmann-Rahtz synthesis of a pyridine derivative. 
 
Although these observations demonstrated the potential of the Bohlmann-Rahtz reaction, 
in synthesis and manufacturing processes, and established the use of acid catalysis for 
this transformation, a substantial quantity of the acid mediator was required. Although no 
examples of successful catalysis have been reported using sub-stoichiometric quantities 
of a Brønsted acid in this transformation, the use of Lewis acid catalysts in this fashion 
have been described. 
 
2.1. Lewis acid catalysis in the Bohlmann-Rahtz cyclodehydration. 
 
Lewis acids such as ZnBr2 and Sc(OTf)3 have been reported to accelerate the Bohlmann-
Rahtz reaction in 20-30 mol% quantities, but a systematic study to optimize this  process 
in particular under microwave-assisted conditions has not been carried out. Thus in order 
to investigate this further, the Bohlmann-Rahtz cyclodehydration was chosen as the first 
system of study. A range of Lewis acids were to be studied in sub-stoichiometric 
quantities to establish which might have potential in a one-pot process.   
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2.1.1. Synthesis of the Bohlmann-Rahtz substrate 35. 
 
Synthesis of the substrate aminodienone 35 was achieved in high yield by the reaction of 
ethyl 3-aminocrotonate (33) and 4-(trimethylsilyl)but-3-yn-2-one (59) in ethanol under 
microwave irradiation at 60 °C (Scheme 39). Under these conditions protodesilylation 
occurred spontaneously in the course of the reaction to give 2-amino-3-
ethoxycarbonylhepta-2,4-dien-6-one (35) after purification by recrystallization from 
hexane-acetone (7:1 v/v).  
 
 
Scheme 39: Synthesis of substrate 35 under microwave-assisted conditions. 
 
 
 
2.1.2. Investigating Lewis acids in the Bohlmann-Rahtz cyclodehydration. 
The effect of Lewis acids in the Bohlmann-Rahtz reaction was first studied using substrate 
35 and ZnBr2 in varying quantities under microwave irradiation at 120 °C to give 
trisusbtituted pyridine 36 (Table 2.1). 
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Table 2.1. Bohlmann-Rahtz cyclodehydration using ZnBr2 catalysis  
  
 
 
Entry Catalyst 
/mol% 
Conditions Outcome Yield%a 
1 150 As shown  84 
2 1 RT, 24 h 36/35  (6:1)b n.d. 
3 1 MeCN 36/35  (7:1)b n.d. 
4 1 MeCN, 2 h  85 
5 1 As shown 36/35  (7:1)b n.d. 
6 3 As shown  99 
7 0 As shown 36/35  (1:1)b n.d. 
a Isolated yield  of pyridine 36 after column chromatography on silica. 
b Ratio of pyridine 36/substrate 35 as determined by 1H NMR spectroscopic analysis of 
the crude reaction mixture. 
n.d. Indicates not determined as multiple products and an impure sample were obtained. 
 
 
The cyclodehydration was investigated in EtOH in the presence of a large excess of Lewis 
acid (150 mol%). In all cases the product was formed but some loss of material was 
observed when an excess of catalyst was present (84% yield) (Table 2.1, entry 1). When 
the cyclodehydration was carried out in EtOH at room temperature for 1 day with a 
catalytic quantity (1 mol%) of Lewis acid, the product was formed but some starting 
material remained (entry 2). Clearly the Lewis acid had a dramatic catalytic role even 
under these mild conditions. Changing the solvent and carrying out the cyclodehydration 
in MeCN under microwave heating with the same excess of Lewis acid (1 mol%) gave 
41 
 
the product but with little difference in outcome (entry 3). Repeating the same reaction 
for entry 3, but with increased reaction time (2 h) cyclodehydration occurred, giving 
pyridine 36 in reasonable yield (85% yield) (entry 4). When the cyclodehydration was 
carried out in EtOH at 120 °C under microwave heating with a catalytic quantity (1 mol%) 
of Lewis acid, the outcome was multiple products were formed and an impure sample 
was obtained (entry 5). Increasing the quantity of Lewis acid (3 mol%) and repeating the 
same conditions for entry 5, gave the product in high yield (99% yield) and without any 
starting material present (entry 6). For comparison when the cyclodehydration was carried 
out in the absence of an added Lewis acid catalyst the crude material contained a 
substantial quantity of unreacted starting material (35/36 =1:1) (entry 7).  
The structure of 36 was confirmed by spectral data from NMR, MS and IR. The mass 
spectrum of 36 showed the presence of a pseudo molecular ion peak (MH) at m/z = 180 
and the HRMS confirmed its formula as C10H14NO2. The IR spectrum of 36 showed a 
strong absorption band at ν 1720 cm–1 due to the carboxylate group. The 1H NMR 
spectrum of 36 showed two characteristic doublets (J = 8 Hz) that resonated at δ = 7.99 
and 6.95 ppm which were attributed to H-4 and H-5 of the pyridine ring, respectively. 
The 13C NMR spectrum showed a singlet signal at δ = 166.5 ppm due to the carbonyl 
carbon. Also, it showed resonances for all pyridine carbons and the two methyl and ethyl 
groups. 
 
These studies confirmed that ZnBr2 catalysis offered great potential in the Bohlmann-
Rahtz reaction as a high yielding method for pyridine synthesis and EtOH would appear 
to be the optimum solvent, giving a single regioisomer. Given these findings, the use of 
alternative Lewis acid catalysts for Bohlmann-Rahtz cyclodehydration was deemed 
worthy of further study. 
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Given that ZnBr2 had been shown to be a highly effective Lewis acid catalyst in the 
challenging step (E/Z isomerization) of the Bohlmann-Rahtz pyridine synthesis, even 
when present in very small quantities (3 mol%), a study was made of alternative Lewis 
acids to see how well they compared in the same transformation (Table 2.2). The use of 
ZnCl2 (entry 2) or ZnI2 (entry 3) in ethanol at 120 °C under microwave irradiation in 1 
mol% quantity gave a similar outcome to the use of ZnBr2 (entry 1) and provided pyridine 
36 in excellent isolated yield. This was considerably more efficient than the use of a 
catalytic quantity of HCl as a Brønsted acid catalyst (entry 4) which gave pyridine 36 in 
only 58% yield. The use of Zn(OTf)2 (1 mol%) (entry 5) was also high yielding, indicating 
that the ligands to the metal had a small influence but ZnII catalysts in general were 
effective in the Bohlmann-Rahtz reaction. Changing the catalyst and the use of alternative 
metal ion catalysts, such as NiII (entry 6), DyIII (entry 7) or FeIII (entry 8), all promoted 
the formation of pyridine 36 but gave a notable reduction in efficiency. 
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Table 2.2. Bohlmann-Rahtz cyclodehydration using different Lewis acid catalysts 
 
 
 
Entry Catalyst (mol%) Outcome Yield%a 
1 ZnBr2 (3)  99 
2 ZnCl2 (1)  92 
3 ZnI2 (1)  99 
4 HCl (1)  58 
5 Zn(OTf)2 (1)  91 
6 NiCl2.6H2O (1) 36 / 35  (6:1)
b 84 
7 Dy(OTf)3 (1) 36 / 35  (6:1)
b 83 
8 FeCl3 (5)  77 
a Isolated yield of pyridine 36 after column chromatography on silica. 
b Ratio of pyridine 36 / substrate 35 as determined by 1H NMR spectroscopic analysis of 
the crude reaction mixture. 
 
These studies confirmed that, in sub-stoichiometric quantities, Lewis acid catalysis 
offered great potential in the Bohlmann-Rahtz reaction. ZnII catalysts appeared to be 
highly efficient and effective even when used in small quantities, but other metal ion 
catalysts did also have promising activity. Given these findings, the role of different 
Lewis acid catalysts in a one-pot microwave-mediated method appeared worthy of further 
study.  
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2.1.3. Lewis acid mediated 2-in-1 Bohlmann-Rahtz pyridine synthesis. 
 
The use of ZnBr2 was investigated in the Bohlmann-Rahtz reaction using  
4-(trimethylsilyl)-3-butyn-2-one (59) and ethyl 3-aminocrotonate (33). Both the Michael 
addition and cyclodehydration had been found to proceed in ethanol under microwave 
irradiation, the second step of which was promoted efficiently using ZnII catalysts. 
However, when a one-pot process was investigated using these substrates (Table 2.3) it 
was found that protodesilylation did not proceed to completion in the presence of the 
Lewis acid catalyst (5 mol%) at 120 °C (entry 1) and a mixture of substrate 36, unreacted 
starting material 33, pyridine 36 and (trimethylsilyl)pyridine 60 was obtained. Under 
slightly more forcing conditions, at a higher temperature, longer reaction time and 
increased ethynyl ketone stoichiometry but reduced Lewis acid loading (entry 2), the 
outcome was a higher proportion of pyridine products 60 over unreacted starting material 
33 or intermediates 36 was obtained, with substrate 35 also present. Under harsher 
conditions, at 160 °C with a longer reaction time (2 h) increased ethynyl ketone 
stoichiometry (3 equivalents) and increased Lewis acid loading (entry 3), a similar 
outcome was obtained, giving a mixture of unreacted starting material 33, pyridines 60 
and 36 and intermediate 35 in slightly altered ratio. Changing the solvent (entry 4) from 
EtOH to toluene, to avoid any solvent chelation to the metal, that might reduce catalyst 
activity, under similar conditions now gave pyridine 60 in good yield. 
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Table 2.3. Bohlmann-Rahtz pyridine synthesis and Lewis acid mediated 2-in-1 process. 
  
 
 
 
Entry  Catalyst  (mol%) Conditions         Outcome a 
1 ZnBr2 (5) 120 
oC, 1 h, 2 equiv, EtOH 33/35/36/60 (8:3:2:2)b 
2 ZnBr2 (2) 130 
oC, 1.5 h, 2.5 equiv, EtOH 33/35/36/60 (3:1:3:2)b 
3 ZnBr2 (15) 160 
oC, 2 h, 3 equiv, EtOH 33/35/36/60  (4:3:4:4)b 
4 ZnBr2 (15) 160 
oC, 2 h, 3 equiv, PhMe 60 (69%) 
a  Outcome describes ratio of species in parentheses or isolated yield after purification by 
column chromatography on silica (entry 4). 
b Ratio determined by 1H NMR spectroscopic analysis of crude reaction mixture. 
 
The structure of 60 was confirmed by spectral data from NMR, MS and IR spectroscopy. 
The mass spectrum of 60 showed the presence of a pseudo molecular ion peak (MH) at 
m/z = 252 and the HRMS confirmed its formula as C13H21NO2Si. The IR spectrum of 60 
showed a strong absorption band at ν 1730 cm–1 due to the carboxylate group. The 1H 
NMR spectrum of 60 showed a characteristic singlet resonance at δ = 7.12 ppm which 
was attributed to H-5 of the pyridine ring. The 13C NMR spectrum showed a signal at δ = 
166.8 ppm due to the carbonyl carbon. Also, it showed resonances for all pyridine carbons 
and the six methyl groups. 
 
These studies did demonstrate the potential for the Lewis acid mediated microwave-
assisted Bohlmann-Rahtz reaction and showed that whilst ethanol was a useful solvent in 
terms of species solvation it was probably retarding the rate, through interacting with the 
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catalyst or solvating the nudeophile. It also served a role in protodesilyation but this was 
incomplete under these conditions. Thus in order to remove this ambiguity and in an effort 
to reduce the ethynyl ketone stoichiometry, an alternative, less volatile ethynyl ketone 
was used in place of 4-(trimethylsilyl)-3-butyn-2-one (59). Thus an alternative series of 
experiments was conducted using 3-hexyn-2-one (61) which would be expected to 
undergo slower Michael addition, but should be more facile in E/Z-isomerization.  
 
Bohlmann-Rahtz pyridine synthesis and Lewis acid mediated 2-in-1 Michael addition-
cyclodehydration using a different ethynyl ketone was investigated in the first instance 
using ZnBr2 as catalyst, replacing butynone 59 with 3-hexyn-2-one (61) (Table 2-4, entry 
1). The reaction was effective, even in EtOH, giving a good yield and thus showing the 
process was feasible and efficient. When the ethynyl ketone 61 stoichiometry was 
reduced to 1.2 equivalents (entry 2) the yield was lower and the presence of ethyl 
acetoacetate (51) was observed in the crude product. Presumably this was formed through 
hydrolysis of enamine 33 using H2O produced in the cyclodehydration. This may have 
occurred as a result of slower Michael addition when less ethynyl ketone 61 was present. 
Alternatively when the Lewis acid FeCl3 (entry 3) was investigated under identical 
conditions, the process worked better than ZnBr2; the Bohlmann-Rahtz cyclodehydration 
proceeded in high yield and gave a single isolated product. However the presence of 
acetoacetate 51 was again observed in the crude product. 
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Table 2.4. Lewis acid mediated 2-in-1 Bohlmann-Rahtz pyridine synthesis using a 
different ethynyl ketone. 
 
 
 
 
Entry 33/61 Lewis acid Yield %a Outcome 
1        1:2 ZnBr2 (20 mol%) 75  
2 1:1.2 ZnBr2 (20 mol%) 67 51 present in crude 
3 1:1.2 FeCl3 (20 mol%) 86 51 present in crude 
4 1:1.2 FeCl3 (20 mol%), 
NH4OAc (20 mol%) 
b  
5        1:1 FeCl3 (20 mol%) 84  
6        1:1 No catalyst 55  
a Isolated yield after column chromatography on silica. 
b Pure product was not obtained.  
 
In case the hydrolysis of enamine 33 had been responsible for lowering the yield, the 
process was repeated in the presence of NH4OAc (entry 4) to convert back any 
acetoacetate 51 formed to enamine 33; however, this seemed to lower the activity of the 
catalyst and gave a mixture of products. Reducing the stoichiometry to a 1:1 ratio of 
enamine 33 / ethynyl ketone 61 (entry 5) gave an excellent yield of product after 
purification by column chromatography. Finally, to confirm the Lewis acid was serving 
a catalytic role, the reaction was repeated in the absence of the catalyst (entry 6); under 
these conditions in fact a reasonable yield of pyridine 62 was obtained (55% yield) 
showing that these high temperature conditions did facilitate Michael addition and 
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subsequent cyclodehydration. However, both Lewis acids appeared to provide some 
improvement over this uncatalyzed process. 
The structure of 62 was confirmed by spectral data from NMR, MS and IR spectroscopy. 
The mass spectrum of 62 showed the presence of a pseudo molecular ion peak (MH) at 
m/z = 207 and the HRMS confirmed its formula as C12H17NO2. The IR spectrum of 62 
showed a strong absorption band at ν 1723 cm–1 due to the carboxylate group. The 1H 
NMR spectrum of 62 showed a characteristic singlet at δ = 6.86 ppm which was attributed 
to H-5 and a quartet (J = 7 Hz) that resonated at δ = 4.39 ppm which was attributed to the 
CH2 of the ethyl ester. The 
13C NMR spectrum showed a signal at δ = 168.9 ppm due to 
the carbonyl carbon. Also, it showed resonances for all pyridine carbons and the three 
methyl and ethyl groups. 
Given that an effective method for rapid pyridine formation had been found under 
microwave irradiation using either ZnBr2 or FeCl3 as catalyst, the scope of these new 
processes was investigated using 1:1 stoichiometry, unless stated otherwise (Table 2.5). 
It was found that the synthesis of pyridine 62 using FeCl3 as a Lewis acid catalyst gave 
improved yield in the one-pot process when compared with ZnBr2 (enties 1 and 2), but 
for the synthesis of pyridine 36 using FeCl3 as a Lewis acid catalyst gave a comparable 
yield in the one-pot process to the use of ZnBr2 (enties 3 and 4) FeCl3 gave good yields 
of the pyridine products using ethyl β-aminocrotonate with a range of ethynyl ketones 
(enties 5 and 6), but using crotononitrile gave very variable yields as shown (enties 7, 8 
and 9) and much lower reaction efficiencies were observed. Pyridine 68 (entry 10) was 
obtained in excellent yield but with less reactive ethynyl ketones much lower reaction 
efficiencies were observed. 
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Table 2.5: Synthesis of pyridines using a Lewis acids catalyst. 
 
 
 
 
Entry Lewis acid R1 R2 R3 Product Yield (%)a 
1 ZnBr2 EtO2C Et CH3 62 67 
2 FeCl3 EtO2C Et CH3 62 84 
3 ZnBr2 EtO2C H CH3 36 88 
4 FeCl3 EtO2C H CH3 36 86 
5 FeCl3 EtO2C Ph CH3 63 83 
6 FeCl3 EtO2C H Ph 64 83 
7 FeCl3 NC H CH3 65 57 
8 FeCl3 NC Et CH3 66 24 
9 FeCl3 NC Ph CH3 67 33 
10 FeCl3 NC H Ph 68 80 
a Isolated yield after purification by column chromatography on silica. 
 
The pyridine products were identified in the case of 62, 63, 66 and 67 by a singlet 
resonance at δ = 6.86, 6.93, 6.88 and 6.78 ppm, respectively, which was attributed to  
H-5 of the pyridine ring, or in the case of 36, 64, 65 and 68 by series of doublet resonance 
at δ = 7.99 and 6.95 ppm, δ = 8.05 and 7.58 ppm, δ = 7.87 and 6.49 ppm and δ = 8.04 and 
7.48 ppm (J = 8 Hz), respectively, which were attributed to H-4 and H-5 of the pyridine 
ring in the 1H NMR spectrum. The IR spectra of 65, 66, 67 and 68 showed an absorption 
band at ν 2195, 2190, 2290 and 2195 cm-1 due to the C≡N group. The IR spectrum of 36, 
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62, 63 and 64 showed a strong absorption band at ν 1720, 1723, 1721, or 1716 cm–1 due 
to the carboxylate group. The 13C NMR spectrum for C≡N containing 65, 67 and 68 
showed a quaternary carbon at δ 24.7, 23.2 and 23.9 ppm due to the nitrile group. The 
mass spectrum of 65 showed a pseudo molecular ion peak at m/z = 133 (MH) and the EI-
mass spectrum showed a molecular ion peak at m/z = 132 (M•+). The HRMS confirmed 
the formula of the molecular ion as C8H8N2. The EI–mass spectrum of 67 showed a 
pseudo molecular ion peak at m/z = 208 and the HRMS of the pseudo molecular ion 
confirmed its formula as C14H12N2. The mass spectrum of 68 showed a pseudo molecular 
ion peak at m/z = 195 (MH) and the EI-mass spectrum showed a molecular ion peak at 
m/z = 194 (M•+). The HRMS confirmed the formula of the molecular ion as C13H11N2.  
 
2.1.4. Bagley-Bohlmann-Rahtz 3-component pyridine synthesis. 
 
Given that an efficient process had been discovered for carrying out Bohlmann-Rahtz 
pyridine synthesis, with Michael addition-cyclodyhydration proceeding in one-pot, using 
either ZnBr2 or FeCl3 as a Lewis acid catalyst, this technology was next applied to a  
3-component reaction. This process had been described before but, in ethanol, relatively 
low yields had been obtained. The studies were initiated using the potentially 
problematic-3-hexyn-2-one (61) to investigate the role of each Lewis acid under 
conductive heating in the presence of ammonium acetate and ethyl acetoacetate (51) 
(Table 2.6). The first conditions investigated in the Bagley-Bohlmann-Rahtz pyridine 
synthesis were carried out at reflux, with ZnBr2 as Lewis acid catalyst in EtOH and in the 
presence of NH4OAc to convert the acetoacetate 51 to enamine 33. In all cases the product 
was formed but with an excess of ethynyl ketone (entry 1) multiple products were formed. 
Using equimolar quantities of 61 and 51 (entry 2) did give the product but in very low 
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yield. The yield was improved with a small excess of hexyone 61  providing pyridine 62 
in 50% yield (entry 3) but other products were formed. Using FeCl3 as Lewis acid (entry 
4), which was highly effective in the Bohlmann-Rahtz reaction, was less effective in the 
presence of NH4OAc, in ethanol, perhaps because Lewis acidity was attenuated by 
solvent or reagent acting as a Lewis base, or because the presence of the Lewis acid was 
interfering with enamine formation.  
 
Table 2.6. Bagley-Bohlmann-Rahtz reaction using Lewis acid catalyst. 
 
Entry Lewis acid (20 
mol%) 
Stoichiometrya Yield %b 
1 ZnBr2 1 : 2 n.d. 
2 ZnBr2 1 : 1 20 
3 ZnBr2 1 : 1.2 50 
4 FeCl3 1 : 1.2 24 
5 FeCl3 in PhMe 1 : 2 93 
a Molar ratio of  51 : 61. 
 b Isolated yield after purification by column chromatography on silica. 
n.d. Indicates not determined as multiple products and an impure sample were obtained. 
 
Although a new method had been established, given the lower efficiency of reactions 
conducted in ethanol in comparison with toluene for the 2-in-1 method using toluene 
(Table 2.3), the 3-component  reaction was investigated in toluene. Avoiding the polar 
protic solvent ethanol would remove any unwanted interaction between solvent and 
Lewis acid and prevent hydrogen bonding from attenuating nucleophile reactivity and so 
could promote reaction. This was found to be the case. Changing to toluene as a solvent 
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(Table 2.6, entry 5) gave the pyridine product 62 in excellent yield when an excess of 
hexynone 61 was used. This compared directly to the use of ZnBr2 in this multi-
component process (96% yield)96 demonstrating that FeCl3 was an effective Lewis acid 
in both Bohlmann-Rahtz pyridine synthesis and Bagley-Bohlmann-Rahtz 
cyclocondensation. 
 
2.2. Tetranuclear coordination clusters as Lewis acid catalysts. 
These studies had established the effectiveness of a range of Lewis acid catalysts 
containing different metal centres in the Bohlmann-Rahtz reaction and related processes. 
Given the different reactivity profile they exhibited, this model reaction looked ideal for 
probing the role of different metal centres in mixed metal catalytic systems. 
 
 
2.2.1. Previous applications of tetranuclear coordination clusters. 
Polynuclear coordination clusters (CCs),97,98 assembled from organic ligands, transition-
metal elements (3d), and/or lanthanide (4f) elements, are a burgeoning class of functional 
materials with fascinating structures.99−104 These materials are already used in areas 
ranging from molecular magnetism,105−113 biology,114−116 molecular imaging,117 magnetic 
resonance,118 and luminescence.119−123 However, one of the most common applications 
for coordination compounds, catalysis, is much less studied for polynuclear 3d/4f 
heterometallic CCs with classical N,O-donor ligands124−130 than for organometallic 
compounds.131,132 
A series of heterometallic coordination clusters (CCs) [NiII2Ln
III
2(L1)4Cl2(CH3CN)2] 
2CH3CN [Ln = Y (1Y), Sm (1Sm), Eu (1Eu), Gd (1Gd), or Tb (1Tb)] can be readily 
prepared by the reaction of (E)-2-(2-hydroxy-3-methoxybenzylidene-amino)phenol) 
(H2L1) with NiCl2·6(H2O) and LnCl3·x(H2O) in the presence of Et3N at room 
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temperature. They are synthesized in quantitative yield in two steps, on up to multigram 
scale, and are air stable for a few months. It has been shown that these bimetallic species 
remain intact in organic and aqueous solutions, by ESI‐MS studies, EPR studies for 1Gd 
and NMR studies for 1Y analogues. Structurally it has been shown that the Zn and the Ln 
centres are very close (approximately 3.3 Å), permitting both metals to coordinate to 
substrates and promote a series of reactions. 
 
Dysprosium triflate, due to its mild nature, has proven to be an excellent catalyst for 
reactions where both nitrogen and oxygen functionalities are present.133 Similarly these 
air-stable CCs containing Dy or Y demonstate efficient catalytic behaviour in the room-
temperature domino ring-opening electrocyclization synthesis of trans-4,5-
diaminocyclopent-2-enones from 2-furaldehyde (Scheme 40). 
 
Scheme 40: Comparison of 1Ln catalytic activity as CCS.a 
Entry Ln Temperature Loadingb (mol%) Time (h) Yield (%) 
1 Dy r. t 1 2 quantitative 
2 Y r. t 1 24 98 
aReaction conditions: 1 mmol amine, 0.5 mmol 2-furaldehyde, 100 mg of 4 Å molecular sieve (MS), 4 
mL of anhydrous MeCN catalyst, room temperature (r.t.). bCatalyst loading calculated per equivalent of 
Dy. 
 
 
Tetranuclear ZnII2Ln
III
2 coordination clusters (CCs) have also been formd to act as 
catalysts for a range of other processes such as the Friedel–Crafts (FC) alkylation of 
indoles with trans-β-nitrostyrenes. Good to excellent yields (76–99%) were obtained at 
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room temperature with catalyst loadings as low as 1.0 mol%. The DyIII and YIII 
coordination clusters have also been used to catalyze the addition of aldehydes or ketones 
to indoles, in a facile route for the synthesis of bisindolylmethane derivatives in up to 
quantitative yield at 2.5-10 mol% loadings. These indole products have recently been 
shown to be useful in the treatment of fibromyalgia,134 as antibacterial agents135 and even 
in the prevention of cancer.135  
The polynuclear clusters were prepared from Ln(NO3)3.xH2O and Zn(NO3)2.6H2O under 
aerobic conditions of H2L in the presence of Et3N in EtOH to give a precipitate which 
subsequently crystallized by vapour diffusion of Et2O in N,N
’-DMF solution, to give the 
air-stable tetranuclear compounds of general formula [Zn2
IILn2
III L4(NO3)2(DMF)2] 
where Ln was Dy (Figure 9). 
 
 
 
Figure 9: Molecular structure of [Zn2
IILn2
IIIL4(NO3)2(DMF)2]. 
 
Finally these heteronuclear Zn/Ln coordination clusters (CCs) have been used as catalysts 
for the multicomponent Mannich-type condensation of amines, aldehydes and boronic 
acids, known as the Petasis borono-Mannich reaction. The reaction proceeds in 
very good to excellent yields (84–98%, 17 products) at room temperature with catalyst 
loadings as low as 1.0 mol%. The cluster [Zn2
IILn2
IIIL4(NO3)2(DMF)2] (Figure 9) 
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exhibited excellent efficacy in the Petasis borono-Mannich MCR at room temperature, 
with 1% loading giving excellent yields in a very short time. 
 
Given this precedent that a number of Lewis acid catalyzed procedures had been observed 
to be promoted by these readily-available heterometallic coordination clusters, often with 
very low catalyst loadings, it was proposed to use clusters incorporating a range of metals 
in Bohlmann-Rahtz processes. These could provide new insights into the role of mixed 
metals in these systems and further expand the synthetic utitily of this pyridine forming 
reaction.  
 
 
2.2.2. Bohlmann-Rahtz cyclodehydration using mixed metal catalysts. 
 
Starting with the Bohlmann-Rahtz cyclodehydration as a model process a range of  
tetranuclear clusters was prepared using previously reported methods,136 incorporating a 
range of different metals, and heated with aminodienone 35. The Bohlmann-Rahtz 
cyclodelydration was investigated using these species at low catalyst loadings (1-11 
mol%) under microwave irradiation (Table 2.7). 
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Table 2.7. Bohlmann-Rahtz cyclodehydration using mixed metal catalysts. 
 
 
 
Entry Catalyst mol% Conditions Outcome Yield%a 
1 [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] 11 As shown  97 
2 [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] 1 As shown  98 
3 [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] 1 RT, 24h 36/35 (6:1)
b n.d. 
4 [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] 1 MeCN 36/35 (7:1)
b n.d. 
5 [Zn2
IIDy2
IIIL4(NO3)2(MeCN)2] 1 As shown 36/35 (5:1)
b 76 
6 [Zn2
IIDy2
IIIL4(NO3)2(MeCN)2] 3 As shown  98 
7 [Zn2
IIY2
IIIL4(NO3)2(EtOH)2] 1 As shown 36/35 (5:1)
b 78 
8 [Zn2
IIY2
IIIL4(NO3)2(MeCN)2] 1 As shown 36/35 (6:1)
b 67 
9 [Ni2
IIDy2
IIIL4(NO3)2(EtOH)2] 1 As shown 36/35 (4:1)
b 62 
10 [Ni2
IIDy2
IIIL4(NO3)2(MeCN)2] 1 As shown 36/35 (4:1)
b 59 
a Isolated yield after column chromatography on silica. 
b Ratio determined by 1H NMR spectroscopic analysis of crude reaction mixture. 
n.d. Indicates not determined as multiple products and an impure sample were obtained. 
 
In all cases studied the pyridine product 36 was formed. The first polynuclear CC 
investigated was [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] which was found to act as an effective 
Lewis acid for Bohlmann-Rahtz cyclodehydration at 11 mol% (entry 1) or 1 mol% (entry 
2) loading. Both of these experiments gave pyridine 36 in excellent yield. It was 
postulated that either metal centre could in principle be acting as the catalytic centre for 
this reaction. Using the same catalyst, [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2], but at room 
temperature for 1 day (entry 3) did give the product 36 predominantly but some starting 
material remained. It was considered that elevated temperature could promote the process 
by facilitating ligand exchange at the metal centre. Investigating a different reaction 
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solvent MeCN (entry 4) at elevated temperature was less effective and gave  unreacted 
starting material. The role of different ligands on the metal was investigated by changing 
the ancillary ligand, [Zn2
IIDy2
IIIL4(NO3)2(MeCN)2]; interestingly, the outcome was that 
unreacted stating material was present and only a 76% yield of product 36 was obtained 
after column chromatography. The reduced efficiency in comparison to 
[Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] could be as a consequence of altered ligand exchange. The 
quality of catalyst was increased to 3 mol% (entry 6) and efficient conversion was 
obtained using this mixed metal catalyst bearing the MeCN ancillary ligand. In order to 
probe the role of the different metals, alternative catalysts were investigated, 
systematically changing one metal for alternatives. The most active catalyst 
[Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] was replaced with [Zn2
IIY2
IIIL4(NO3)2(EtOH)2] (entry 7) 
which caused a significant reduction in activity. Also, when 
[Zn2
IIDy2
IIIL4(NO3)2(MeCN)2] was replaced with [Zn2
IIY2
IIIL4(NO3)2(MeCN)2] (entry 8) 
similar reductions in yield were observed in line with previous observations. Little 
catalyst activity was found when [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] was replaced with 
[Ni2
IIDy2
IIIL4(NO3)2(EtOH)2] in either case (enties 9 and 10).  
These studies confirmed that these species at low catalyst loadings were effective Lewis 
acids for Bohlmann-Rahtz cyclodehydration and thus offered great potential  as catalysts 
in the Bohlmann-Rahtz reaction. The [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] catalyst appeared to 
be highly efficient and effective even when used in small quantities, but other mixed metal 
catalysts did also have promising activity. Given these findings, the role of mixed metal 
catalysts in a one-pot microwave-mediated method was investigated. 
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2.2.3. Bohlmann-Rahtz pyridine synthesis using a mixed metal catalyst. 
 
Given the effectiveness of these mixed metal catalysts in cyclodehydration, studies were 
made of Bohlmann-Rahtz pyridine synthesis using the most active Lewis acid from this 
class [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2]. Initial studies using 4-(trimethylsilyl)but-3-yn-2-one 
(59) were frustrated by incomplete protodesilylation which occurred under the reaction 
conditions. Thus the reaction of  enamine 33 with an alternative ethynyl ketone 3-hexyn-
2-one (61), with [Zn2
IIDy2
IIIL4(NO3)2(EtOH)2] was investigated under microwave 
irradiation, by heating at 150 oC for 1 h, to give pyridine 62 in 85% yield as a single 
regioisomer (Seheme 41). 
 
 
 
Seheme 41: pyridine 62 synthesis using a mixed metal catalyst. 
 
Given that in the absence of a Lewis acid, this process gave a 1:1 ratio of pyridine 62 : 
unreacted enamine (33) (Table 2.4), the mixed metal catalyst clearly was promoting the 
Michael addition/cyclodehydration process. For reaction in ethanolic solvent this 
outcome compared very favourably with other Znп catalysts and established this process 
as a optional new method in Bohlmann-Rahtz chemistry under microwave irradiation. 
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CHAPTER THREE 
Bohlmann-Rahtz synthesis of pyridine [2,3-d]pyrimidines 
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3. Bohlmann-Rahtz synthesis of pyridine [2,3-d]pyrimidines. 
 
 3.1. Introduction.     
In recent years pyrido[2,3–d]pyrimidine derivatives have received considerable interest 
as a consequence of their structural relationship to both pyridines and pteridines,137 and 
the biological potential of anti-folates to elicit responses as antitumour,138 antibacterial,139  
anti–inflammatory140 and insecticidal agents.141 The Bohlmann-Rahtz reaction has been 
applied to pyridine-fused heterocycles,  notably pyrido[2,3-d]pyridines, as a route to the 
core motif of deazapterins and folates of interest. One of the first studies of this kind 
investigated the synthesis of pyrido[2,3-d]pyrimidines using ethynyl ketones under Lewis 
acid catalyzed conditions.142 For example, the synthesis of 2-substituted pyrido[2,3-
d]pyrimidines 70 from the corresponding (diaminopyrimidinyl)propanone 71 or in one 
pot from the reaction of diaminopyrimidinone 69 and butynone 59 was reported using the 
Bohlmann-Rahtz reaction (Scheme 42). When a solution of the pyrimidine derived 
Bohlmann-Rahtz intermediate 71 and zinc(II) bromide (20 mol%) in dimethylsulfoxide 
was heated overnight at 110 °C the heteroannelated product 70 was produced in >99% 
yield (Scheme 42).142 Furthermore, when a solution of diaminopyrimidinone 69 and 
butynone 59 in dimethylsulfoxide was heated at 110 °C for 72 hours in the presence of 
either zinc(II) bromide (20 mol%) or ytterbium(III) triflate (20 mol%), the zinc(II) 
catalyzed reactions gave pure pyrido[2,3–d]pyrimidine 70a,b in 92 and 89% yield, 
respectively, whereas the ytterbium(III) catalyzed process gave a slightly impure product 
70a,b in 94 and 91% respective yield (Scheme 42).142 
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Scheme 42: Bohlmann–Rahtz synthesis of pyrido[2,3–d]pyrimidinones 70 using a Lewis 
acid as catalyst. 
 
However, for these highly unreactive enamine precursors very forcing reaction conditions 
were required over extended periods of time. Furthermore, the products of Bohlmann-
Rahtz processes for these substrates, the pyridopyrimidinones and their derivatives, share 
many physical properties with the related pteridines and suffer from poor solubility in 
most solvents, complicating synthetic approaches; thus fast, simple and efficient methods 
for the preparation of these targets are needed. 
 
The structural identity of pyrido[2,3-d]pyrimidine 70 prepared by Bohlmann-Rahtz 
processes and the regiochemistry of the reactions conducted in acetic acid and N,N-
dimethylformamide has been confirmed by further experimentation.143 (3-Oxobut-1-
enyl)pyrimidine 71 has been heated to 180 °C to facilitate Bohlmann-Rahtz 
cyclodehydration and the product obtained was identical to pyrido[2,3-d]pyrimidine 70  
prepared by a one-pot Bohlmann-Rahtz cyclocndesation reaction in every respect.142 This 
was also an indication that both the one and two-step methods for pyrido[2,3-
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d]pyrimidine synthesis based upon a Bohlmann-Rahtz pyridine annelation, were effected 
with total regiocontrol (Scheme 43) in 72–95% yield depending on the solvent used, and 
proceeded by C-alkylation and subsequent cyclodehydration of the Michael addition 
product (71).142 
 
 
 
Scheme 43: Summary of solvent effects in the synthesis of pyridopyrimidine 70. 
 
 
3.2. Rapid method for the synthesis of pyrido[2,3-d]pyrimidines. 
 
In an effort to elaborate a much simpler approach to pyridopyrimidines, the use of 
microwave irradiation and a Brønsted acid was investigated. Ciufolini had reported the 
use of neat acetic acid to mediate the Bagley-Bohlmann-Rahtz process in his synthesis of 
the core domain of the thiopeptide antibiotic micrococcin.68 The application of this 
solvent to pyridopyrimidine targets could serve two roles: firstly, it might circumvent the 
need for extended reaction times and an additional Lewis acid in this process; secondly, 
it could overcome the poor solubility associated with this heterocyclic framework. 
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Preliminary studies carried out in the group,144 verified that this approach seemed 
feasible: when a mixture of 2,4-diamino-6-hydroxypyimidine (69) and 3-butyn-2-one 
(72) was irradiated in neat acetic acid at 120 oC for 30 min, 2-amino-7-methylpyrido[2,3-
d]pyrimidin-4-one (70) was obtained in 90% yield after simple precipitation of the 
product on addition of water (Scheme 44). 
 
 
Scheme 44: Synthesis of 2-amino-7-methylpyrido[2,3-d]pyrimidin-4(3H)-one (70).  
 
Although this demonstrated that this system was highly effective for 
diaminopyrimidinone 70, less reactive aminouracil derivatives had not been screened in 
this promising process. Thus a series of uracil derivatives (73-74) was reacted with a 
range of ethynylketones in acetic acid under these conditions. The ethynyl ketone 41 was 
made from the oxidation of 1-phenylprop-2yn-1-ol (79) using a solution of Dess-Martin 
periodinane  in dichloromethane, in a 20 min reaction to give propynone 41 as a yellow 
powder in 81% yield. With the ethynyl ketone 41 to hand it was found to undergo 
successful Bohlmann-Rahtz reaction with 6-amino-1,3-dimethyluracil (73) in one-pot in 
only 30 min in acetic acid, giving the product 75 in excellent yield (entry 1) after a simple 
precipitation. Use of an alternative ethynyl ketone that had a relatively low boiling point, 
the product was formed successfully, but in slightly lower efficiency (entry 2). Using 
alternative uracil derivative 74 with phenyl propynone 41 or butynone 72 was also 
successful giving pyridopyrimidine 77 (entry 3) and 78 (entry 4) in 80 and 99% yield, 
respectively. 
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Table 2.8. Synthesis of pyridopyrimidine derivatives using the Bohlmann-Rahtz reaction 
in acetic acid. 
 
Entry SM R1 R2 R3 Product  Yield % 
1 73 Me Me Ph 75 >98 
2 73 Me Me Me 76 76 
3 74 H Me Ph 77 80 
4 74 H Me Me 78 99 
(73)   6-Amino-1,3-dimethyluracil.  
(74)   6-Amino-1-methyluracil. 
(75)   1,3-Dimethyl-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
(76)   1,3,7-Trimethylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
(77)   1-Methyl-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
(78)   1,7-Dimethylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
        
Unfortunately reactions involving 6-aminouracil 81 and the reaction of certain 
aminouracil derivatives 73 and 74 with 3-hexyn-2-one (61), 4-phenyl-3-butyn-2-one (80) 
or 4-(trimethylsilyl)-3-butyn-2-one (59) all resulted in complex mixtures of products that 
could not be easily purified. Despite this limit in substrate scope, which has been 
catalogued for these less-reactive uracil derivatives under related conditions,145 it would 
appear that the Bohlmann-Rahtz reaction in acetic acid is effective in some cases to 
provide rapid access to pyridopyrimidinone derivatives. 
These studies expanded the scope the acid catalysed Bohlmann-Rahtz reaction and 
applied this to the use of challenging substrates to deliver heterocyclic frameworks of 
potential biological interest. 
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4. Synthesis of Aminopyridines using the Bohlmann-Rahtz 
reaction. 
These studies have established new methods to carry out the Bohlmann-Rahtz reaction in 
one pot for the synthesis of pyridines and pyrido[2,3-d]pyrimidines using Brønsted and 
Lewis acid catalysts. However, the substrate scope of the Bohlmann-Rahtz reaction has 
changed little since the original discovery. Given the biological value of aminopyridines, 
it was considered that the use of an alternative enamine would enable 2-aminopyridine 
derivatives 84 to be generated in this reaction. This could require replacing the stable 
enamine 82 of the traditional Bohlmann-Rahtz reaction with a methylenediamine 83 and 
investigating if this changed the mechanistic couse and synthetic outcome (Scheme 45). 
 
 
Scheme 45: The traditional Bohlmann-Rahtz reaction and the proposed new process for 
the synthesis of 2-aminopyridines 84. 
Diaminoacrylate derivative 85 (EWG = CO2Et) was chosen as a suitable 
methylenediamine 83 for study. It has been shown146 that methylenediamines derived 
from phenyl cyanomethanesulfonate do react to give 2-aminopyridines in Guareschi-
Thorpe reactions. The Bohlmann-Rahtz reaction does have similarities to this process and 
so the methylenediamine could display a similar reactivity profile. However, pyrimidine 
products have been formed under acidic or basic conditions from reaction of ethynyl 
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ketones with amidines and the diaminopropenoate should be in dynamic equilibrium with 
the carbethoxyacetamidine tautomer (86) (Scheme 46).147-149 The reaction course could 
give aminopyridine 85 if it proceeded through enamine C-functionalization (path a) or 
alternatively could provide the corresponding pyrimidine derivative 87 if it proceeded 
through N-functionalization (e.g. path b); if both processes operated a mixture of products 
could be obtained. There have been a number of reports which indicate that these  
bis-nucleophiles give pyrimidine cyclocondensation products. It has been shown that 
carbethoxyacetamidine 86 undergoes self-condensation under basic conditions to give a 
pyrimidine derivative 88150 and the cyclocondensation of benzoylacetamidine provides 
2-phenacylpyrimidine derivatives.151 Furthermore, acetamidine 86 when reacted with a 
prop-2-enylidine bis-electrophile gave a mixture of pyridine and pyrimidine 
cyclocondensation products, in a 2:3 ratio respectively.152 Nonetheless there was some 
encouraging precedent: the hydroacetate salts of iminopropanoates react by C-alkylation 
in a Michael addition for the synthesis of Hantzsch dihydropyridines.153 Thus the 
Bohlmann-Rahtz reaction of these derivatives was worthy of investigation. 
 
Scheme 46: Alternative reaction pathways due to methylenediamine 83 -acetamidine 86 
tautomerization. 
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4.1. Synthesis of 2-aminopyridines using the Bohlmann-Rahtz reaction. 
 
Iminopropanoate hydrochloride 86∙HCl was prepared by a modification of a known 
route,153 but carried out under microwave-assisted conditions and without the use of 
anhydrous HCl gas, to dramatically shorten reaction times and simplify the experimental 
procedure. Ethyl imidate hydrochloride 89∙HCl was transformed to the free base 89 
(observed, spectroscopically, as predominantly the enamine tautomer in CHCl3) and 
reacted with ammonium chloride in EtOH under microwave irradiation at 120 °C for 1 h 
(Scheme 47) to give acetamidine hydrochloride 86∙HCl after a simple trituration. 
 
Scheme 47: The preparation of iminopropanoate hydrochloride 86·HCl.  
The preferred tautomer in solution (NMR solvent DMSO-d6) was inferred from the 
1H 
NMR spectroscopic data. The appearance of two separate peaks at δ = 9.16 and 8.88 ppm, 
both with an integral of 2 and assigned to NHH and the peak at 3.63 ppm (integral of 2), 
assigned to CH2, suggested the amidine tautomer and were consistent with 
1H and 13C 
NMR data in the literature.154 
 
With acetamidine 86 to hand, attention was given to the Bohlmann-Rahtz pyridine 
synthesis. An alternative purification method to column chromatography was considered 
as purification on silca had been found to give very low isolated yields of the  
2-aminopyridine product,155 It was suspected that the basicity of the compounds was 
responsible, thus making these derivatives difficult to isolate on acidic silica. The use of 
an ion-exchange SCX-2 SPE (Biotage) column, optimum for basic compound extraction, 
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comprising propylsulfonic acid functionalized silica (Figure 10) was used as an 
alternative purification method for isolating the 2-aminopyridine products. The 
functionalized silica ‘traps’ basic components (amino groups for example as the 
conjugate acid salt), allowing any non-basic components to be eluted and separated. The 
free base can then be regained from its conjugate acid by eluting with a stronger base, in 
this case ammonia in ethanol. The acetamidine hydrochloride salt 86·HCl and ethynyl 
ketone 41 was irradiated at 150 °C in ethanol, immobilized on SCX-2 SPE column and 
eluted with EtOH–NH4OH (aq; 35%) (5:1 v/v) or ethanolic ammonia (2 M) to give  
2-aminopyridine 90 in 73% isolated yield (Scheme 48). 
O
Si
Si O
OH
Si (CH2)3SO3-H
 
Figure 10: Propylsulfonic acid functionalised silica. 
 
 
 
Scheme 48: Synthesis of 2-aminopyridine 90. 
 
Acid catalysis has previously been reported as a method of facilitating the Bohlmann-
Rahtz pyridine synthesis.58,61 The reaction between the amidine hydrochloride salt 
(86·HCl) and ethynyl ketone 41 was repeated, this time with Na2CO3 present as base to 
explore if HCl that was present was catalyzing the reaction. However, surprisingly, in the 
presence of base 2-aminopyridine 90 was again formed but this time in 92% yield after 
purification by immobilization on a SCX-2 SPE column (Scheme 49). 
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Scheme 49: Synthesis of 2-aminopyridines 90 under basic conditions. 
 
In this example, the yield was higher compared to the products obtained when ethanol 
only was used as a solvent without pre-treatment (- HCl) using Na2CO3 as base. Even 
more promising was that there was no evidence of pyrimidine formation by 1H NMR 
spectroscopic analysis of the crude reaction product, where doublets with coupling 
constants (J) of approximately 4 Hz would be expected.149 This reaction produced the  
2-aminopyridine derivative 90, as a single regioisomer and in very good yield in a highly 
selective process. 
The use of a different ethynyl ketone 3-butyn-2-one (72) was explored in both the acid 
and base mediated reactions and was found to give the 2-aminopyridine products with a 
slight increase in yield. When 3-butyn-2-one (72) was heated with amidine (86) at 150 °C 
in the presence or absence of Na2CO3 base, the corresponding pyridine (84) was formed 
in 82% or 84% yield, respectively (Scheme 50 and 51). Overall there was little difference 
in the yields of these reactions which gave 2-aminopyridine 85 under microwave-
asssisted conditions. It is interesting to note here again that the yield under ethanol only 
conditions was marginally less than that obtained using Na2CO3 as base. This could imply 
that the Na2CO3 was acting in some catalytic role in this process, but it is more likely that 
the presence of acid led to some degradation, reduced the efficiency of the isolation 
procedure or retarded the reaction rate probably as a consequence of amidine 86 
protonation. 
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Scheme 50: Synthesis of 2-aminopyridines 85. 
 
 
Scheme 51: Synthesis of 2-aminopyridine 85 under basic conditions. 
 
Further studies were carried out under microwave-assisted conditions to attempt to extend 
the scope of this method to prepare different 2-aminopyridines, substituted at the  
4-position. Reaction of 4-phenyl-3-butyn-2-one (80) and amidine (86) hydrochloride salt, 
in ethanol as the solvent at 150 °C formed 2-aminopyridine 91 in 70% yield (Scheme 52) 
or 52% yield in the presence of Na2CO3 as base (Scheme 53). 
 
 
Scheme 52: Synthesis of 2-aminopyridine 91 on changing the ethynyl ketone. 
 
 
Scheme 53: Synthesis of 2-aminopyridine 91 under basic conditions. 
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Additionally, reaction of amidine 86 and hex-3-yn-2-one (61) gave 2-aminopyridine 92 
in 29% yield (Scheme 54) or 54% yield in the presence of Na2CO3 as base (Scheme 55). 
The lower yields observed here compared with those obtained from the synthesis of 91 
(Scheme 53) suggesting that substituents at the 4-position hinder the synthesis of the  
2-aminopyridines using this method. Nevertheless, these results do suggest that this 
method for the preparation of 2-aminopyridines can be applied to other substrates, 
although further optimization may be required. 
 
 
Scheme 54: A different 2-aminopyridine 92 formed on changing the ethynyl ketone. 
 
Scheme 55: The yield obtained under basic conditions. 
The microwave-assisted synthesis of 2-aminopyridines using a Bohlmann-Rahtz type 
route has prepared four different 2-aminopyridines, albeit in a variety of isolated yields. 
This is a new reactivity profile that was previously unknown for the Bohlmann-Rahtz 
pyridine synthesis, that lends itself well to a simple isolation procedure involing catch 
and release on an acidic resin. 
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4.2. Synthesis of 2-aminopyridines using flow processing. 
 
As shown in (Figure 11) The flow reactor Vapourtec was configured using a combination 
of the R-2 Pump Module and R-4 Reactor Module. The System Solvent Bottle was filled 
with solvent, and the Reagent Stock Bottles A and B were filled with solutions of starting 
material in solvent. 
   
Figure 11: Schematic Flow Reactor Configurations. 
 
 
With acetamidine 86 to hand, consideration was given to the Bohlmann-Rahtz pyridine 
synthesis using a flow reactor to extend the scope of this method to prepare  
2-aminopyridines. The flow synthesis of these targets was investigated using a simplified 
bench-top continuous flow setup and a SCX-2 SPE reagent in column using a low boiling 
point alcohol (EtOH) at high temperature (150 oC) reaction of 3-butyn-2-one (72) 0.1 M 
(flow rate 0.057 mL/min) and amidine (86) hydrochloride salt 0.1 M (flow rate 0.054 
mL/min), in ethanol as the solvent at 150 °C formed 2-aminopyridine 85 in 75% yield 
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after purification by immobilization on a SCX-2 SPE column and elution with ethanolic 
ammonia (2 M) (Scheme 56). The 2-aminopyrididne 85 prepared by flow technology 
compared favourably and was indistinguishable to the batch technology product. 
 
 
 
Scheme 56: Flow synthesis of 2-aminopyridine 85. 
 
Further studies were carried out under similar conditions to prepare different  
2-aminopyridines, substituted at the 4-position. Reaction of 4-phenyl-3-butyn-2-one (80) 
and amidine (86) hydrochloride salt, in ethanol as the solvent at 150 °C formed  
2-aminopyridine 91 in 69% yield after purification by immobilization on a SCX-2 SPE 
column and elution with ethanolic ammonia (Scheme 57). 
 
 
 
Scheme 57: A different 2-aminopyridine 91 formed on changing the ethynyl ketone. 
 
Additionally, reaction of amidine 86 and ethynyl ketone 41 gave 2-aminopyridine 90 in 
69% yield (Scheme 58). Overall there was a small difference in the yields of these 
reactions which gave the corresponding 2-aminopyridine under flow reactor conditions. 
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This could be due to the presence of acid leading to some degradation, a reduction in the 
efficiency of the isolation procedure or retardation of the reaction rate probably as a 
consequence of amidine protonation. 
 
 
 
Scheme 58: Synthesis of 2-aminopyridine 90 on changing the ethynyl ketone. 
 
The flow method synthesis of 2-aminopyridines using a Bohlmann-Rahtz type route has 
prepared three different 2-aminopyridines, albeit in a variety of isolated yields. This is a 
new reactivity profile, previously unknown for the Bohlmann-Rahtz pyridine synthesis, 
that lends itself well to a simple isolation procedure involing catch and release technology 
under continuos flow processing. 
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5.  H/D- Exchange in Aminopyridines. 
5.1. Introduction. 
Once inside the body, a drug molecule must avoid a multitude of attacks by the metabolic 
system before it reaches its biological target. The body’s metabolic pathways breakdown 
drug molecules into inactive derivatives and then ejects them, meaning that many drugs 
need to be taken more frequently than they might otherwise need. One proposed way to 
improve the metabolic behaviour of a drug is to substitute some of the hydrogen atoms in 
the molecule with heavier deuterium. Carbon-deuterium bonds are stronger and shorter 
than the equivalent bonds to hydrogen, leading to differences in reactivity that can be up 
to six to 10 times slower. So if breaking a C-H bond is responsible for a drug being 
metabolised faster than is ideal, substituting that hydrogen with deuterium may slow the 
molecule’s breakup. The end result being that the drug can be taken less often, say once 
a day rather than twice. Because deuterium is an isotope of hydrogen this atom 
substitution causes little change in the shape, size, charge or the biological effects of the 
molecule. Only the pharmacokinetics, how the drug is processed by body, should change. 
In so doing the drug half-life could be improved; reduced variability in the metabolism 
of the drug molecule between patients and improved tolerability could also potentially be 
achieved.156 It has recently been reported that deuterated drug isotopologues may be 
unexpectedly non obvious in patent law,162 differentiating these compounds from prior 
art. This makes deuterated compounds essential targets for study, especially when 
coupled with interesting biological or pharmacological properties. 
Deuterium is already widely used as an isotopic label to study the metabolism of drug 
candidates both in the lab and in humans. Previously, however, it had never been used in 
a final drug molecule but that situation might be about to change. Approval of the first-
ever deuterated drug may well be imminent. This idea of using deuterium to shield 
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pharmaceutical agents against unwanted metabolism is not a new concept: in the 1970s 
US pharma company Merck & Co put the first deuterated drug into clinical trials. 
 The demand for compounds multiply-labelled with stable isotopes has increased 
dramatically in recent years.157,158 Deuterated derivatives have been used as internal 
standards for quantifying human and animal pharmacokinetic and metabolism 
experiments in drug development, and as mechanistic probes to determine reaction 
pathways. Deuterated standards exhibit similar physical and chemical properties to their 
non-deuterated isotopologues, but differ on account of their mass difference. If this mass 
difference is large enough to separate signals from natural isotope patterns, quantitative 
analysis is possible.159  
 
A number of strategies are available for the preparation of compounds containing multiple 
deuterium atoms.163-165 It may be easiest to synthesize these compounds using 
isotopically-labelled precursors. This has the advantage of being predictable, using the 
route to the ‘natural’ isotopologue, but can be time consuming and may require expensive 
reagents and/or the development of additional sequences. The use of protium-deuterium 
exchange in the target molecule or late-stage intermediate, has the potential to be more 
rapid, efficient and cost-effective and removes the need for further developmental work, 
but requires a method to introduce multiple deuterium atoms in an efficient and 
predictable fashion.159 H/D exchange can also provide a useful model system for protium-
tritium exchange.157,160,161 Complementary methods are available for carrying out this 
exchange process such as acid- or base-catalyzed reactions or metal-mediated processes, 
all of which are possible with aliphatic, aromatic or heteroaromatic compounds. The base-
induced hydrogen-deuterium exchange in pyridines is much more facile and rapid than 
the reaction of benzene, with the hydrogen at the 4-position of pyridine being described 
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as easier to exchange than H3 or H2.166,167 Direct hydrogen-deuterium exchange of 
pyridines with deuterium oxide can be effected at 200 to 400 °C. However, the 
regioselective base-induced hydrogen-deuterium exchange  of pyridines can be achieved 
by directed deprotonation and subsequent quenching of the metalated (lithiated) pyridine 
with deuterium oxide; e.g. formation of the 3-deuterated derivative 94 from pyridine 93 
(Scheme 59).168  
 
Scheme 59: Directed base-induced hydrogen-deuterium exchange in pyridines.168,169 
 
Unprotected pyridine-2-carboxylic acids (picolinic acids), e.g. the parent 95, may be 
selectively deuterated next to the carboxy function using lithium 2,2,6,6-
tetramethylpiperidide (LTMP) followed by treatment with deuterium oxide (Scheme 59). 
Alternatively selective 2- (and 6)-deuteration of pyridines 96 to give isotopologues 97 is 
possible using heterogeneous catalysis (Scheme 60).170 
 
Scheme 60: Hydrogen-deuterium exchange using heterogeneous catalysis.170 
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5.2. H/D Exchange Using D2O. 
During the 1960’s and 70’s the use of H/D-exchange reactions was an area of great 
interest leading to many significant advances in methods and understanding.158 After this 
period, interest in H/D exchange was largely neglected until the mid 1990’s in which a 
renewed surge of interest emerged. This was primarily a consequence of the increase in 
demand for isotopically labelled compounds for pharmacokinetic and metabolic studies 
during drug development,171,172 mechanistic investigations into catalysts and reaction 
pathways173,174,175 or research into C-H bond activation.176,177 For the production of an 
isotopically labelled compound a method involving H/D exchange is commonly 
preferable as it avoids multi-step synthesis using labelled precursors which are generally 
expensive and thus is a lot more efficient and cost-effective. Other related methods 
include halogen-deuterium exchange178,179  and reductive deuteration.180 
One of oldest known methods for H/D exchange is pH dependent H/D exchange. For 
example, exchange can occur via the use of a base- or acid-catalysed enolization, with 
H/D exchange occurring at the active positions in the molecule by application of 
deuterated Brønsted acids. Such methods often require the deactivation of the compound 
to prevent the reverse exchange occurring.158 
H/D exchange can also occur without the presence of a strong acid or base but just using 
deuterium oxide alone. This exchange occurs on acidic carbon-bonded hydrogen atoms, 
and works due to the ability of deuterium oxide to act as either an acid or a base. Such 
exchange is possible with a number of different compounds and the experimental 
conditions vary dramatically. For example, Junk and Catallo achieved almost complete 
H/D exchange during the deuteration of phenanthrene (98) by carring out the reaction at 
380-430 °C (Scheme 61).181 Harsh conditions were used similarly by Werstiuk and Ju to 
carry out H/D exchange on pyridine derivatives, reporting good yields (>80%) and high 
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levels of deuteration in the 3-, 5- and 6-positions of 2-hydroxypyridine (99) and  
2-mercaptopyridine (100) (Scheme 62).167 
 
 
 
Scheme 61: H/D exchange of phenanthrene (98). 
 
 
 
Scheme 62: H/D exchange of pyridine derivatives. 
 
Edlund and Berson showed that it is not always necessary to use such extreme conditions 
for H/D exchange.182 During the synthesis of [1,1,3,3-D4]2-indanone (101), exchange 
occurs by repeatedly heating the precursor in D2O under reflux, to attain the deuterated 
product with high % deuteration. The milder conditions again led to high regioselectivity 
(Scheme 63) although quite an involved method was required. 
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Scheme 63: Highly regioselective deuteration of 2-indanone (101) 
 
The H/D exchange of methyl ketones has also been reported under base catalysed 
conditions.183 Berthelette and Scheigetz achieved such exchange using aryl methyl 
ketones.183 The exchange varied greatly with substrate, base and solvent but was achieved 
in high yield and percentage deuteration using 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU). Deuteration of a base sensitive diketone 102 was also achieved without 
decomposition by the addition of triethylamine (Scheme 64). 
 
 
 
Scheme 64: Deuteration of a base-sensitive diketone 102. 
 
H/D exchange at the α-position of a number of pyridine derivatives was first observed by 
Zoltewicz,184 but has also been described recently. When dimethylpyridine 103 was 
heated under basic conditions at 180 °C in D2O for 5.5 d (Scheme 65), exchange at C-6 
occurred more rapidly than at the other ring positions, but very forcing conditions were 
required.185 Similarly, pyridine (104) when heated to 260 °C for 48 h in D2O underwent 
H/D exchange, in high regioselectivity for the α-position, to give dideuterated 104a. The 
same process carried out at 200 °C for 24 h gave only 15% D incorporation at this 
position.167 Given that many recent efforts have been directed towards H/D exchange of 
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pyridine derivatives,186-193 such as the highly site-selective one-step α-labelling of 
pyridines and N-heteroaromatic compounds using deuterium gas and a rhodium or 
ruthenium catalyst,194 and the faster H/D exchange observed in 4-pyrrolidino pyridines,167 
we set out to establish a simple one-step method for site-selective protium- deuterium 
exchange using neutral D2O that would proceed under microwave irradiation, in a 
commercial instrument using readily-automated conditions in the absence of any catalyst. 
 
 
Scheme 65:  H/D exchange at the α-position of pyridines using D2O.168,186 
 
Investigating the H/D exchange of 2-aminopyridine (105), 3-aminopyridine (106), and  
4-aminopyridine (107) in neutral D2O under microwave irradiation at 190 °C for just 2 h 
(Table 5.1) established differences in the efficiency of H/D exchange at different 
positions across this small series of substrates. For 2-aminopyridine (105), only moderate 
H/D exchange was observed at all positions under these relatively mild conditions, as 
might be expected, with very little overall regioselectivity (entry 1). The reaction of  
3-aminopyridine (106) under these conditions was much more selective, with good 
incorporation at C-2 and yet very low levels of H/D exchange at all other positions, 
including at C-6 (entry 2). Unfortunately, increasing the reaction time gave no further 
improvement in D incorporation at C-2 (80%). However, 4-aminopyridine (107) 
underwent rapid H/D exchange at the α-positions, even at this relatively low temperature, 
indicating its unusual high reactivity in the process (entry 3). It is noteworthy that 
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contrasting behaviour has been described by Zoltewicz in a study of H/D exchange of  
4-amino-2,6-dimethylpyridine, with respect to 2,6-lutidine, under neutral and acidic 
conditions.184e Carrying out the H/D exchange in neutral D2O at lower temperatures 170 
(entry 4) or 180 °C (entry 5), gave 4-aminopyridine (107c or 107d) with much less 
efficient D incorporation at all positions. 
 
Figure 12: %D Incorporation in aminopyridines under neutral conditions. 
 
 
 
Table 5.1. %D Incorporation after microwave irradiation at 190 °C for 2 h in neutral 
D2O
a 
 
Entry Substrate Product C-2 C-3 C-4 C-5 C-6 Yieldb 
1 105 105a - 54 52 53 56 72 
2 106 106a 80 - 6 3 12 66 
3 107 107a 98 50 - 50 98 57 
4c 107 107c 39 5 - 5 39 52 
5d 107 107d 67 17 - 17 67 57 
a As determined by 1H NMR spectroscopic analysis after introduction of an internal standard by 
acetylation (AcCl, K2CO3, acetone, RT, 3 h), followed by aqueous work-up.  
b Yield refers to the isolated yield% of product after microwave irradiation of the substrate in D2O in a 
sealed Pyrex™ tube at 190 °C, unless stated otherwise, for 2 h (hold-time) by moderation of the initial 
magnetron power (300 W), followed by cooling and an acid-base work-up. 
c Reaction was carried out at 170 °C. 
d Reaction was carried out at 180 °C. 
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5.3. H/D Exchange Using DCl. 
There are two possible exchange methods in acid-catalysed exchange: either strong 
deuterated Brønsted acids or alternatively a Lewis acid with a deuterium source can be 
used to deuterate an aromatic compound. The use of both of these deuteration methods, 
combined, has also been described. Wahala and Rasku demonstrated this combination on 
a number of substrates including flavonoids, isoflavonoids and lignans.195 With the use of 
a mixture of D3PO4, BF3, and D2O, good yields and high levels of deuteration at the 
activated positions were achieved at temperatures between 20 and 55 °C. The reaction 
involved many cycles over a period of one to four days.  
Rasku and Wahala did further work showing that with more severe conditions it was 
possible, using diadzein and enterolactone as a substrate, to deuterate at poorly activated 
positions.196 The synthesis gave almost full deuteration of d8-enterolactone (>99%) 
including at the inactive meta positions (Scheme 66). 
 
Scheme 66: H/D exchange using both a Brønsted and Lewis acid. 
 
Given the potential of acid-mediated exchange, repeating our studies using acid-
mediation under relatively mild conditions could help to understand the high reactivity of 
4-aminopyridine (107) towards α-exchange (Table 5.2). It was expected that this would 
provide a basis for the site-selectivity of proton-deuteron exchange by electrophilic 
aromatic substitution and a point of comparison with Zoltewicz’s mechanistic studies. 
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The microwave-assisted exchange reactions were repeated in the presence of DCl. Under 
these conditions 2-aminopyridine (105b) showed D incorporation to a similar degree at 
C-4 and C-6 but positions activated towards electrophilic aromatic substitution (C-3 and 
C-5) exhibited a dramatic increase in D incorporation (both 94%), as expected. The same 
phenomenon was observed in the deuteration of 3-aminopyridine (106), with an increase 
in incorporation at the activated α-positions of 106b (96% at C-2), making it a useful 
synthetic procedure. The observation most worthy of note was that H/D exchange of  
4-aminopyridine (107) completely reversed under acidic conditions, with high levels of 
incorporation now observed at C-3 and C-5 (positions activated to electrophilic aromatic 
substitution) and yet minimal incorporation at the pyridine α-carbons of 107b. This 
demonstrated that mechanisms operating in neutral D2O (Table 5.1) were distinct from 
the electrophile-mediated process (Table 5.2) for 4-aminopyridine (107) and so were 
worthy of further study as a site-selective method for D-incorporation.  
Figure 13: %D Incorporation in aminopyridines under acidic conditions. 
 
Table 5.2. %D Incorporation after microwave irradiation at 190 °C for 2 h in D2O in the 
presence of DCla 
Entry Substrate Product C-2 C-3 C-4 C-5 C-6 Yieldb 
1 105 105b - 94 54 94 54 70 
2 106 106b 96 - 15 3 34 60 
3 107 107b 9 92 - 92 9 56 
a As determined by 1H NMR spectroscopic analysis after introduction of an internal standard by acetylation (AcCl, 
K2CO3, acetone, RT, 3 h), followed by aqueous work-up.  
b Yield refers to the isolated yield% of product after microwave irradiation of the substrate in D2O in the presence of 
DCl (4 equiv.) in a sealed Pyrex™ tube at 190 °C for 2 h (hold-time), by moderation of the initial magnetron power 
(300 W), cooling, and an acid-base work-up. 
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Given the high site-selectivity for H/D exchange of 4-aminopyridine (107) in neutral 
D2O, a range of substrates was investigated under the newly-found set of conditions 
(microwave irradiation at 190 °C, 2 h) to establish the scope of the method. The nature of 
the substituent, its position, and even the heterocycle were varied (Table 5.3). For some 
substrates, reaction in both the presence and absence of DCl was investigated to see if a 
reversal of the regioselectivity was observed. It was found that N-alkyl groups exhibited 
minimal side-chain exchange under these conditions (entries 3-7) and their presence 
slightly retarded H/D exchange at C-3 and C-5, presumably as a consequence of steric 
effects. Excellent incorporation at C-2 and C-6 (95-98%) was observed for 108-110 under 
neutral conditions, also with high levels of regiocontrol (entries 3, 5 and 6).  
4-Aminoquinoline (111) showed similar behaviour (entry 8), although the efficiency of 
incorporation at C-2 in 110a (89%) was reduced slightly with respect to its pyridine 
counterpart 107a (98%). D incorporation in 4-pyrrolidinopyridine (110b) and  
4-aminoquinoline (111b) was seen to reverse by carrying out the procedure in the 
presence of DCl (entries 7 and 9), demonstrating that this method proceeds by a 
contrasting mechanism and complements acid-mediated exchange. For quinoline 
products 111a and 111b, minimal exchange was noted in the carbocyclic ring under both 
sets of conditions. Efficient incorporation was only affected marginally (89%) by the 
presence of a methyl group, at C-3 in 112a (entry 10) or at C-2 in 113a (96%) – the latter 
also showing efficient incorporation (97%) at C-1' (entry 11). The effect of halogen 
substituents (114-116) on H/D efficiency did vary with position: with a halogen at C-3 
high efficiency (98%) and regioselectivity for C-2 was observed (entries 12 and 13), but 
the 2-chloride 116 did not exchange efficiently (entry 14) perhaps as a consequence of its 
reduced basicity. Interestingly, the 3-iodide 115a exhibited relatively high D 
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incorporation at both α-positions (entry 13; 98 and 75%) whereas the 3-bromide did not 
(entry 12; 98 and 34%).  
Finally, exchange in both 4-aminopyrimidine (117a) and 2-aminopyrazine (118a) was 
less rapid (entries 14 and 15), the corresponding substrates postulated as being less 
reactive in the process as a consequence of their reduced basicity (cf pKaH  
4-aminopyrimidine 5.7l; 2-aminopyridine 6.86; 4-aminopyridine 9.17).197 In cases for 
which H/D exchange was efficient and highly-selective the isolated yield of the product 
was of preparative value (57-97% yield). 
Figure 14: %D Incorporation in aminopyridines under neutral or acidic conditions. 
 
Table 5.3: %D Incorporation of substituted 4-aminopyridines and related heterocycles 
after microwave irradiation at 190 °C for 2 h in D2O in the presence or absence of DCl
a. 
Entry DCl Product C-2 C-3 C-5 C-6 C-7 C-8 C-1' C-2' C-3' Yieldb 
1 × 107a 98 50 50 98 - - - - - 57 
2 √ 107b 9 92 92 9 - - - - - 56 
3 × 108a 98 22 22 98 - - <4 - - 91 
4 √ 108b <4 96 96 <4 - - <4 - - 82 
5 × 109a 97 6 6 97 - - <4 - - 97 
6 × 110a 95 9 9 95 - - - <4 <4 96 
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7 √ 110b <4 74 74 <4 - - - <4 <4 97 
8 × 111a 89 23 9 <4 <4 9 - - - 69 
9 √ 111b 19 98 10 <4 <4 10 - - - 74 
10 × 112a 94 - 8 93 - - <4 - - 97 
11 × 113a - 5 8 96 - - 97 - - 84 
12 × 114a 98 - 17 34 - - - - - 82 
13 × 115a 98 - 25 75 - - - - - 93 
14 × 116a - 42 30 30 - - - - - 98 
15 × 117a 64 - 22 58 - - - - - 26 
16 × 118a - 52 17 17 - - - - - 61 
a As determined by 1H NMR spectroscopic analysis, after introduction of an internal standard (entries 1-3, 7-15) by 
acetylation (AcCl, K2CO3, acetone, RT, 3 h), followed by aqueous work-up and purification by column chromatography 
on silica if required; or by reference to a known quantity of dioxane as an external standard (entries 4-6). 
b Yield refers to the isolated yield% of product after microwave irradiation of the substrate in D2O in a sealed Pyrex™ 
tube at 190 °C for 2 h (hold-time) in the presence or absence of DCl (4 equiv.), by moderation of the initial magnetron 
power (300 W), cooling, and an acid-base work-up. 
 
Given the fast kinetics of H/D exchange of 4-aminopyridines under neutral conditions, 
and the high regioselectivity of the process, which was distinct from acid-mediated 
exchange198 a distinct operating mechanism was considered. In accordance with the 
kinetic and mechanistic studies by Zoltewicz on base-catalyzed H/D exchange of  
N-substituted pyridinium ions,184d and exchange of methylpyridines in dilute acid,184e this 
method could be a specific acid-general base catalyzed process influenced by internal 
return (Scheme 67). The equilibrium almost certainly involves protonation of the 
substrate I by the solvent (D2O), giving a pyridinium conjugate acid II, which can then 
be deprotonated by the lyate anion (or substrate B) to give pyridinium ylide III. If this 
was the case, the efficiency of the exchange process for 4-aminopyridines would be 
attributed to the increased pyridine basicity in general base catalysis, increased stability 
of the pyridinium ylides III upon deprotonation, or a shift from general base catalysis to 
an internal return limited process, with no significant general base catalysis and slow 
dissociation of a hydrogen-bonded ylide III-conjugate acid complex, as a consequence 
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of the reduced acidity of the pyridinium conjugate acid.184d A profile of reactivity 
dependent upon aminopyridine basicity and proceeding in equilibrium via pyridinium 
ylide III explains most of the observations (Table 5.3), such as reduced exchange in 
 4-amino-2-chloropyridine (116), 4-aminopyrimidine (117) and 2-aminopyrazine (118). 
It is likely other factors are involved. For example, D incorporation at C-2 (80%) vs C-6 
(12%) (Table 5.1) of 3-aminopyridine (pKaH 5.98) indicates a role of ylide III stability, 
which could also be responsible for the high C-2 selectivity for D incorporation in  
3-bromide 16a and low D incorporation (56%) at C-6 for 2-aminopyridine (pKaH 6.86).
197 
It is also possible alternative mechanisms could be in competition. However, no matter 
what the operating mechanism or mechanisms might be, this relatively-mild method 
under neutral conditions would seem to tolerate a range of 4-aminopyridine basicities, 
give quite predictable outcomes and is well-suited to this structural motif, including a 
benzo-fused analogue. 
 
 
Scheme 67: Possible mechanism for D incorporation in 4-aminopyridine I-H involving H/D 
exchange equilibria of pyridinium ylide III 
 
In conclusion, these studies have shown that H/D exchange for 4-aminopyridines occurs 
rapidly at the α-position under neutral conditions and is essentially complete in just 2 h 
in D2O at 190 °C under microwave irradiation. This single cycle process can provide 
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deuterated isotopologues in reasonable yield without any added catalyst or specialist 
equipment. For these substrates this method exhibits complementary selectivity to acid-
mediated exchange methods, is mechanistically distinct and thus provides a valuable 
route to structurally-defined isotopomers or isotopologues based upon this heterocyclic 
scaffold. 
5.4. H/D Exchange Using D2O and DCl sequentially. 
 
In order to understand the observed phenomena and the high reactivity of  
4-aminopyridine (107) towards α-exchange under relatively mild conditions, the study 
was repeated but, this time, the product from α-exchange was irradiated again in presence 
of DCl (Table 5.4). It was anticipated this would provide a new efficient method for 
incorporating multiple deuterium labels by complementing the site selectivity of  
α-exchange with the site-selectivity of proton-deuterium exchange by electrophilic 
aromatic substitution, thus providing a comparison with Zoltewicz’s mechanistic studies. 
A range of substrates was thus submitted to a new one-pot procedure, involving sequential 
reaction first in D2O under neutral conditions followed be addition of DCl and a second 
period of irradiation. Under the 2 step conditions, 4-aminopyridine (107f) showed D 
incorporation at all ring positions, with high levels of incorporation at C-3 and C-5 
(positions activated to electrophilic aromatic substitution) and good incorporation at the 
pyridine α-carbons of 107f. This demonstrated that mechanisms operating in neutral D2O 
complemented the acid-mediated exchange (Table 5.1). For some substrates, significant 
improvements were observed. It was found that N-alkyl groups exhibited no side-chain 
exchange under these conditions (entries 2-5), showed similar behaviour and excellent 
incorporation at all positions. The effect of halogen substituents (114-116) did vary with 
position: with a halogen at C-2 or C-3 high incorporation efficiency (98%) was observed 
at C-3 or C-2 (entries 8 and 9), respectively, whereas the presence of a methyl group 
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showed high D incorporation at both α-positions (entry 7). Interestingly, 112 did not 
exchange efficiently (entry 6) under these conditions other than at the α-position.   
Figure 15: %D Incorporation in aminopyridines under neutral conditions then acidic 
conditions. 
 
Table 5.4: %D Incorporation of substituted 4-aminopyridines and related heterocycles  
after microwave irradiation at 190 °C for 2 h in D2O followed by irradiation in the 
presence of DCla.    
Entry Product C-2 C-3 C-5 C-6 C-7 C-8 C-1' C-2' C-3' Yieldb 
1 107f 94 96 96 94 - - - - - 58 
2 108c 95 87 87 95 - - <4 - - 84 
3 109c 95 95 95 95 - - <4 - - 74 
4 110c 97 97 97 97 - - - <4 <4 65 
5 111c 97 97 <4 <4 <4 <4 - - - 62 
6 112c 96 - 63 70 - - <4 - - 75 
7 113c - 97 78 96 - - 98 - - 67 
8 114c 98 - 10 26 - - - - - 86 
9 115c 98 - 18 34 - - - - - 96 
10 116c - 98 75 17 - - - - - 92 
a As determined by 1H NMR spectroscopic analysis, after introduction of an internal standard (entries 1-3, 7-15) by 
acetylation (AcCl, K2CO3, acetone, RT, 3 h), followed by aqueous work-up and purification by column chromatography 
on silica if required; or by reference to a known quantity of dioxane as an external standard (entries 4-6). 
b Yield refers to the isolated yield% of product after microwave irradiation of the substrate in D2O in a sealed Pyrex™ 
tube at 190 °C for 2 h (hold-time) in the presence or absence of DCl (4 equiv.), by moderation of the initial magnetron 
power (300 W), cooling, then irradiation again in the presence of DCl under similar conditions, followed by cooling 
and an acid-base work-up. 
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These studies demonstrated that 4-aminopyridines can undergo H/D exchange under 
neutral conditions at comparitively low temperatures and short reaction times. These 
exchange equilbria complement and can be combined with acid-mediated H/D exchange 
reactions to give new experimental protocols that are fast, convenient and efficient. 
Furthermore, they provide isotopologues bearing multible D labels and so may be well 
suited for application in the study of pharmacokinetic and metabolic properties. 
Conclusion. 
Recently Bohlmann–Rahtz pyridine synthesis has provided a convenient route for the 
synthesis of various substituted pyridine products. The process has been modified in this 
work to be rapid, simple, operate under mild conditions and high yielding. We have 
shown that substituted pyridines could be synthesized efficiently and in high yields under 
microwave conditions from readily-available precursors in what is essentially a relatively 
short reaction time. The use of novel Lewis acids for this process has been investigated 
and it has been discovered that FeCl3 exhibits a similar profile of reactivity to ZnBr2 in 
Bohlmann-Rahtz pyridine synthesis, providing the opportunity to improve the yield, rate, 
catalyst loading and substrate tolerance of this transformation. Furthermore, the 
behaviour of little studied Lewis acid catalysts containing heteronuclear metal clusters in 
this reaction has been studied, providing new insights into their chemical properties, new 
understanding of the catalytic role and new capability for Bohlmann-Rahtz 
transformations. The application of Bohlmann-Rahtz methods to the synthesis of  
2-aminopyridines and pyridine-fused targets has further expanded the scope of this 
reaction. 
The deuteration of pyridine derivatives using microwave irradiation is a valuable process 
and has provided insights into the selectivity and efficiency of H/D exchange reactions 
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under both acidic and neutral conditions. Whilst the understanding of acid-mediated 
electrophilic substitution is reasonably well established, the combination of such 
reactions with the neutral process, and the remarkable ease with which 4-aminopyridines 
undergo H/D exchange under neautral conditions, allowed for direct comparison, giving 
a greater insight into the selectivity and chemistry of exchange processes. It has been 
shown that the H/D exchange of pyridine derivatives in the absence of DCl proceeds with 
remarkable ease and is often highly regioselective for exchange at the α-position. In 
general, the yields for this microwave-assisted procedure are good, the reactions are 
relatively fast and high levels of deuterium incorporation are observed. In conclusion, this 
is a useful procedure for the synthesis of deuterated pyridines that should find use in the 
chemist’s modern toolkit. 
 
Future work. 
This thesis has revealed new substrate scope for the Bohlmann-Rahtz reaction and shown 
it can be used in the synthesis of 2-aminopyridines. For this study only a single diamine 
was investigated, but the scope of this reaction could be expanded in the study of 
alternative ene-diamines to provide 2-aminopyridines bearing a range of different 
electron-withdrawing groups at the 3-position. Further work on the synthesis of pyridines 
bearing alternative N-containing groups has been a focus of subsequent work in the group 
and remains an important goal to widen the applicability of the Bohlmann-Rahtz reaction. 
However, perhaps the most promising area of study for the future would be the use of 
heteronuclear metal clusters as catalysts in the Bohlmann-Rahtz reaction. These studies 
revealed their high activity in cyclodehydration and one-pot pyridine synthesis. 
Expanding these studies to demonstrate the scope and further applicability of these 
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methods may reveal new facets of their reactivity and deliver new improved experimental 
procedures so is worthy of further investigation. 
H/D exchange reactions promise to be important in future years and these studies have 
revealed some intriguing new processes. The findings from H/D exchange under both 
acidic and neutral conditions could be complemented with metal-catalyzed processes to 
expand their scope, and even combined with acid-mediated deuterium-protium exchange 
to deliver highly site-selective methods for poly- or mono-deuteration, respectively. The 
deuteration of pyridine derivatives using homogenous platinum catalysts would be one 
system that might be worthy of future investigation to compare results with previous 
work. 
In conclusion, these studies have provided many new methods for the synthesis and 
functionalization of pyridine-containing compounds. It is anticipated that extending these 
studies to biologically-relevant scaffolds and other heterocyclic motifs will expand the 
utility of this work and, it is hoped, will ensure that the discoveries made as part of this 
thesis will find widespread application in the future. 
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6. Experimental. 
6.1. General Procedures. 
Commercially available reagents were used without further purification. Analytical thin 
layer chromatography was carried out using aluminium-backed plates coated with 
Merck Kieselgel 60 GF254 that were visualised under UV light (at 254 and/or 360 nm). 
Microwave irradiation experiments were performed using a self-tunable CEM 
Discover® focused monomodal microwave synthesiser at the given temperature, 
measured using the instrument’s in-built IR sensor, by varying the irradiation power 
(initial power given in parentheses). Infra-red (IR) spectra were recorded in the range 
4000-600 cm-1 using a Perkin–Elmer 1600 series FTIR spectrometer using an ATR 
probe and thin films between NaCl plates for liquid samples or as a nujol mull and are 
reported in cm-1. Nuclear magnetic resonance (NMR) spectra were recorded using a 
Varian VNMRS instrument operating at 400 or 500 MHz in CDCl3 at 25 °C unless 
stated otherwise and were reported in ppm; J values were recorded in Hz and 
multiplicities were expressed by the usual conventions. Low-resolution mass spectra 
(MS) were determined using electron ionization (EI). In vacuo refers to evaporation at 
reduced pressure using a rotary evaporator and diaphragm pump, followed by the 
removal of trace volatiles using a vacuum (oil) pump. 
 
 
6.2. General procedure for microwave-assisted synthesis of  
2-aminopyridines using hydrochloride salt 86∙HCl 
 
A solution of ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl) (1 equiv) and 
the ethynyl ketone (1.05 equiv) in ethanol (3 mL) was irradiated at 150 °C for 1.5 h 
(hold-time) in a pressure-rated glass tube (10 mL) using a CEM Discover® microwave 
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synthesizer by moderation of the initial magnetron power (200 W). After cooling in a 
flow of compressed air, the solution was immobilized on a Biotage ISOLUTE SCX-2 
column and eluted with EtOH–NH4OH (aq; 35%) (5:1 v/v) to give the title compound. 
 
 
6.3. General procedure for microwave-assisted synthesis of  
2-aminopyridines using free base 
An ethanolic solution of ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl)  
(1 equiv) was pre-treated with sodium carbonate (1 equiv) for 10 min. After filtering, 
the ethynyl ketone (1.05 equiv) was added and the mixture in ethanol (3.5 mL) was 
irradiated at 150 °C for 1.5 h (hold-time) in a pressure-rated glass tube (10 mL) using 
a CEM Discover® microwave synthesizer by moderation of the initial magnetron power 
(200 W). After cooling in a flow of compressed air, the solution was immobilized on a 
Biotage ISOLUTE SCX-2 column and eluted with EtOH–NH4OH (aq; 35%) (5:1 v/v) 
or ethanolic ammonia (2 M) to give the title compound. 
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Synthesis of ethyl 3-amino-3-ethoxypropenoate (ethyl 3-ethoxy-3-
iminopropionate). 
 
 
 
Ethyl 3-ethoxy-3-iminopropionate hydrochloride (89∙HCl) (978 mg, 2.22 mmol) and 
K2CO3 (1380 mg, 10.0 mmol) were partitioned between Et2O (10 mL) and H2O (10 
mL). The organic extract was separated, dried (MgSO4) and evaporated in vacuo to 
give the title compound (760 mg, 95%) as a colourless oil, which was used without 
further purification; νmax (neat) /cm-1 3400, 3300, 1741, 1659; δH (500 MHz; CDCl3) 
/ppm 6.16 (2H, s, NH2), 4.14 (1H, s, CH), 4.07 (2H, q,  J = 7.1 Hz, OCH2), 3.90 (2H, 
q, J = 7.0 Hz, OCH2), 1.28 (3H, t, J = 7.1 Hz, Me), 1.21 (3H, t, J = 7.1 Hz, Me); δC 
(125 MHz, CDCl3) /ppm 171.1 (C), 168.4 (C), 64.8 (CH), 63.7 (CH2), 58.7 (CH2), 14.7 
(Me), 14.4 (Me); m/z (EI) 159 (M•+, 100%). 
 
Synthesis of ethyl 3-amino-3-iminopropionate hydrochloride. 
 
 
 
A solution of ethyl 3-amino-3-ethoxypropenoate (86) (760 mg, 4.78 mmol) and NH4Cl 
(270 mg, 5.0 mmol) in EtOH (4.0 mL) was irradiated in a pressure-rated glass tube (10 
mL) at 120 °C for 1 h (hold-time) using a CEM Discover® microwave synthesizer by 
moderation of the initial magnetron power (200 W). After cooling in a flow of 
compressed air, the solution was filtered, evaporated in vacuo and triturated with 
diethyl ether to give the title compound (923 mg, 78%) as a colourless solid, which was 
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used without further purification; νmax (neat) /cm-1 3300, 3095, 1738, 1687; δH (500 
MHz; d6-DMSO) /ppm 9.16 (2H, bs, NHH), 8088 (2H, bs, 2H, NHH), 4.15 (2H, q, J 
= 7.1 Hz, OCH2), 3.63 (2H, s, H-2), 1.22 (3H, t, J = 7.1 Hz, Me); δC (125 MHz,  
d6-DMSO) /ppm 166.7 (C), 163.6 (C), 61.9 (CH2), 38.2 (CH2), 14.4 (Me); m/z (EI) 130 
(M•+, 100%). 
 
 
 
Synthesis of ethyl 2-amino-6-methylnicotinate. 
 
 
 
A solution of ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl) (150 mg, 0.90 
mmol) and 3-butyn-2-one (64 mg, 0.95 mmol) in EtOH (3.5 mL) was irradiated at 150 
°C for 1.5 h (hold-time) in a pressure-rated glass tube (10 mL) using a CEM Discover® 
microwave synthesizer by moderating the initial power (200 W). After cooling in a 
flow of compressed air the solution was partitioned between aqueous NaHCO3 solution 
and EtOAc (10 mL). The aqueous layer was further extracted with EtOAc (4 × 10 mL) 
and the organic extracts were combined and evaporated in vacuo. Purification by 
immobilization on a Biotage ISOLUTE SCX-2 column, eluting with EtOH–NH4OH 
(aq; 35%) (5:1 v/v), gave the title compound (140 mg, 87%) as a brown powder, mp 88 
°C (Found MH+, 181.0971. C9H13N2O2 [MH] requires 181.0972); νmax (neat)/cm-1 
3425, 3263, 2986, 1686, 1616, 1586, 1247, 1106, 841, 781, 721; δH (500 MHz; 
CDCl3)/ppm 8.01 (1H, d, J = 8.0 Hz, H-4), 6.90-6.40 (2H, bs, NH2), 6.46 (1H, d, J = 
8.0 Hz, H-5), 4.31 (2H, q, J = 7.1 Hz, CH2), 2.38 (3H, s, 6-Me), 1.36 (3H, t, J = 7.1 
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Hz, Me); δC (125 MHz, d6-DMSO/CDCl3)/ppm 171.7 (C), 168.0 (C), 164.2 (C), 145.1 
(CH), 116.6 (CH), 107.4 (C), 65.4 (CH2), 29.1 (Me), 19.3 (Me); m/z (EI) 180 (M
•+, 
100%). 
 
 
 
 
Synthesis of ethyl 2-amino-6-phenylnicotinate. 
 
General Procedure I, using ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl) 
(250 mg, 1.5 mmol) and 1-phenylpropyn-2-one (205 mg, 1.575 mmol) in EtOH (3.5 
mL), gave the title compound (268 mg, 73%) as a yellow solid, mp 108 °C (Found 
MH+, 243.1129. C14H15N2O2 [MH] requires 243.1128); νmax (neat)/cm-1 3428, 3283, 
2980, 1690, 1622, 1583, 1243, 1094, 922, 755, 699; δH (500 MHz; CDCl3)/ppm 8.21 
(1H, d, J = 8.1 Hz, H-4), 8.00 (2H, d, J = 7.1 Hz, H-2',6'), 7.48-7.44 (3H, H-3',4',5'), 
7.09 (1H, d, J = 8.1 Hz, H-5), 7.00-6.00 (2H, bs, NH2), 4.38 (2H, q, J = 7.1 Hz, CH2), 
1.41 (3H, t, J = 7.1 Hz, Me); δC (125 MHz, CDCl3)/ppm 167.0 (C), 160.8 (C), 159.4 
(C), 140.8 (CH), 138.6 (C), 129.7 (CH), 128.6 (CH), 127.3 (CH), 109.6 (CH), 104.9 
(C), 60.7 (CH2), 14.3 (Me); m/z (EI) 243 (M
•+, 25%), 242 (100). 
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Synthesis of ethyl 2-amino-6-(4-chlorophenyl)nicotinate. 
 
General Procedure II, using ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl) 
(150 mg, 0.90 mmol), 1-(4-chlorophenyl)-2-propyn-1-one (156 mg, 0.948 mmol) and 
sodium carbonate (150 mg, 0.90 mmol) in EtOH (3.5 mL), gave the title compound 
(180 mg, 72%) as a brown solid, mp 122 °C (Found MH+, 277.0737. C14H14ClN2O2 
[MH] requires 277.0738); νmax (neat)/cm-1 3493, 3374, 3007, 2983, 2942, 1684, 1679, 
1559; δH (500 MHz; CDCl3)/ppm 8.17 (1H, d, J = 8.0 Hz, H-4), 7.93 (2H, d, J = 8.0 
Hz, H-2',6'), 7.40 (2H, d, J = 8.0 Hz, H-3',5'), 7.00 (1H, d, J = 8.0 Hz, H-5), 6.64 (2H, 
bs, NH2), 4.35 (2H, q, J = 7.0 Hz, CH2), 1.39 (3H, t, J = 7.0 Hz, Me); δC (125 MHz, 
CDCl3)/ppm 166.9 (C), 160.4 (C), 159.2 (C), 140.9 (CH), 136.9 (C), 135.8 (C), 128.8 
(CH), 128.6 (CH), 109.2 (CH), 105.2 (C), 60.9 (CH2), 13.9 (Me); m/z (EI) 277 (M
•+, 
32%), 276 (100). 
 
Synthesis of ethyl 2-amino-6-(4-methoxyphenyl)nicotinate. 
 
General Procedure II, using ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl) 
(150 mg, 0.90 mmol), 1-(4-methoxyphenyl)-2-propyn-1-one (152 mg, 0.948 mmol), 
and sodium carbonate (150 mg, 0.90 mmol), in ethanol (3.5 mL), gave the title 
compound (174.2 mg, 71%) as a brown solid, mp 103 °C (Found MH+, 273.1232. 
C15H17N2O3 [MH] requires 273.1234); νmax (neat)/cm-1 3490, 3269, 3371, 2965, 2965, 
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1684, 1606, 1559; δH (500 MHz; CDCl3)/ppm 8.13 (1H, d, J = 8.1 Hz, 4-H), 7.95 (2H, 
d, J = 7.8 Hz, H-2',6'), 6.98 (1H, d, J = 8.1 Hz, H-5), 6.94 (2H, d, J = 7.8 Hz, H-3',5'), 
6.80-6.20 (2H, bs, NH2), 4.33 (2H, q, J = 7.0 Hz, CH2), 3.82 (3H, s, OMe), 1.37 (3H, 
t, J = 7.0 Hz, Me); δC (125 MHz, CDCl3) 167.1 (C), 161.1 (C), 160.2 (C), 159.3 (C), 
140.6 (CH), 131.0 (C), 128.7 (CH), 114.0 (CH), 108.8 (CH), 104.2 (C), 60.6 (CH2), 
55.3 (Me), 14.3 (Me); m/z (EI) 272 (M•+, 100%). 
 
 
 
 
Synthesis of ethyl 2-amino-6-methyl-4-phenylnicotinate. 
 
General Procedure II, using ethyl 3-amino-3-iminopropionate hydrochloride (6∙HCl) 
(270 mg, 1.62 mmol), 4-phenyl-3-butyn-2-one (270 mg, 1.70 mmol) and sodium 
carbonate (270 mg, 1.62 mmol), in ethanol (3.5 mL), gave the title compound (216 mg, 
52%) as a brown solid, mp 139 °C; νmax (neat)/cm-1 3443, 3272, 2977, 1682, 1606, 
1582, 1241; δH (500 MHz; CDCl3)/ppm 7.33-7.30 (3H, H-3',4',5'), 7.20 (2H, m, H-
2',6'), 6.41 (1H, s, H-5), 6.29 (2H, bs, NH2), 3.88 (2H, q, J = 7.1 Hz, OCH2), 2.37 (3H, 
s, 6-Me), 0.69 (3H, t, J = 7.1 Hz, Me); δC (125 MHz, CDCl3)/ppm 168.5 (C), 160.3 
(C), 158.7 (C), 153.8 (C), 141.5 (C), 127.9 (CH), 127.4 (CH), 115.2 (CH), 104.7 (C), 
60.4 (CH2), 24.2 (Me), 13.1 (Me); m/z (EI) 256 (M
•+, 100%). 
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Synthesis of ethyl 2-amino-4-ethyl-6-methylnicotinate. 
 
 
 
General Procedure II, using ethyl 3-amino-3-iminopropionate hydrochloride (86∙HCl) 
(200 mg, 1.26 mmol), 3-hexyn-2-one (128 mg, 1.32 mmol), and sodium carbonate (200 
mg, 1.26 mmol) in ethanol (3.5 mL), gave the title compound (133 mg, 54%) as a 
brown solid, mp 141 °C (Found MH+, 209.1282. C11H17N2O2 [MH] requires 
209.1285); νmax (neat)/cm-1 3450, 3269, 3147, 2972, 1686, 1619, 1586; δH (500 MHz; 
CDCl3)/ppm 6.33 (1H, s, 5-H), 6.19 (2H, bs, NH2), 4.33 (2H, q, J = 7.0 Hz, OCH2), 
2.78 (2H, q, J = 7.0 Hz, 4-CH2CH3), 2.30 (3H, s, 6-Me), 1.36 (3H, t, J = 7.0 Hz, Me), 
1.16 (3H, t, J = 7.0 Hz, 4-CH2Me); δc (125 MHz, CDCl3)/ppm 168.3 (C), 160.3 (C), 
159.4 (C), 157.2 (C), 114.8 (CH), 104.6 (C), 60.7 (CH2), 28.6 (CH2), 23.9 (Me), 15.1 
(Me), 14.0 (Me); m/z (EI) 208 (M•+, 100%). 
 
 
Synthesis of 2-amino-3-ethoxycarbonylhepta-2,4-dien-6-one. 
 
A mixture of ethyl 3-aminocrotonate (0.20 mL, 1.6 mmol) and 4-(trimethylsilyl)but-3-
yn-2-one (0.52 mL, 3.2 mmol) in dry ethanol (4 mL) was irradiated at 60 °C for 60 min 
in a sealed pressure-rated reaction tube (10 mL) using a CEM Discover® microwave 
synthesizer by moderation of the initial magnetron power (100 W). After cooling in a 
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flow of compressed air, the solution was evaporated in vacuo. Purification by 
recrystallization from hexaneacetone (7:1 v/v) gave the title compound (310 mg, 
100%) as a yellow solid, mp 123124 °C (lit.1 mp 125.5–126.4 °C) (Found M•+, 
197.1053. C10H15NO3 [M] requires 197.1052); max(neat)/cm–1 3332, 1740, 1554, 1489, 
1443, 1352, 1310, 1277, 1200, 1183, 1111, 1023; δH (400 MHz; DMSOd6)/ppm 9.20-
8.50 (2H, bs, NH2), 7.45 (1H, d, J = 15.0 Hz, CH=CHCOCH3), 6.38 (1H, d, J = 15.0 
Hz, CH=CHCOCH3), 4.15 (2H, q, J = 7.1 Hz, CH2CH3), 2.45 (3H, s, Me), 2.10 (3H, s, 
Me), 1.22 (3H, t, J = 7.1 Hz, CH2CH3); δC (100 MHz; DMSOd6)/ppm 199.7 
(CH3C=O), 170.5 (C=O), 166.5 (C-NH2), 140.4 (CH=CHCOCH3), 122.0 
(CH=CHCOCH3), 95.3 (C=CCO2CH2CH3), 59.9 (CH2CH3), 29.2 (COCH3), 23.5 
(CH3C=C), 15.3 (CH3CH2); m/z (EI) 197 (M
•+·, 35), 179 (50), 151 (100), 108 (85). 
 
Synthesis of ethyl-2,6-dimethylpyridine-3-carboxylate. 
 
 
 
A mixture of 2-amino-3-ethoxycarbonylhepta-2,4-diene-6-one (700 mg, 3.55 mmol) 
and ZnBr2 (0.131mg, 0.50 mmoL) as a catalyst in toluene (15 mL) was irradiated at 120 
°C for 1 h in a sealed pressure-rated reaction tube (10 mL) using a CEM Discover® 
microwave synthesizer by moderation of the initial magnetron power (100 W). After 
cooling in a flow of compressed air, water (10 mL) was added and the mixture was 
stirred for 10 min. The solution was extracted with ethyl acetate (3 × 25 mL) and the 
combined organic layers were washed successively with water and brine, dried 
(MgSO4) and evaporated in vacuo. Purification by column chromatography on silica, 
eluting with light petroleum-EtOAc (3:1 v/v), gave the title compound (610 mg, 99%) 
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as a light brown oil (Found MH+, 180.1019. C10H14NO2 [MH] requires 180.1019); max 
(neat)/cm–1 3681, 2981, 2866, 2076, 1720, 1591, 1370, 1280, 1149, 1032, 839, 715; δH 
(500 MHz; CD3OD)/ppm 7.99 (1H, d, J = 8.0 Hz, H-4), 6.95 (1H, d, J = 8.0 Hz, H-5), 
4.27 (2H, q, J = 7.1 Hz, CH2), 2.72 (3H, s, Me), 2.47 (3H, s, Me), 1.30 (3H, t, J = 7.1 
Hz, CH2CH3); δC (125 MHz; CD3OD)/ppm 166.5 (C=O), 160.9 (C), 159.2 (C), 138.5 
(CH), 122.6 (C), 120.2 (CH), 60.8 (CH2), 24.6 (Me), 24.6 (Me), 14.1 (Me); m/z (EI) 
180 (MH+, 15%), 179 (M•+, 55), 134 (100), 133 (35). 
 
Alternative microwave-assisted method using FeCl3 catalyst. 
A solution of ethyl 3-aminocrotonate (150 mg, 1.16 mmol), FeCl3 (38 mg, 0.23 mmol) 
and 3-hexyn-2-one (112 mg, 1.16 mmol) in ethanol (3 mL) was irradiated at 150 °C for 
1 h in a pressure-rated glass tube (10 mL) using a CEM Discover® microwave 
synthesizer (initial power 200 W). After cooling in a flow of compressed air, the 
mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous layer 
was extracted with EtOAc (3 x 20 mL) and the organic extracts were combined, washed 
successively with saturated aqueous NaHCO3 solution (20 mL) and brine (20 mL), 
dried (MgSO4) and evaporated in vacuo. Purification by column chromatography on 
silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title compound (202 mg, 84%) as 
a brown oil with identical spectroscopic properties. 
 
Alternative method at reflux using FeCl3 catalyst. 
A solution of ethyl acetoacetate (150 mg, 1.15 mmol), FeCl3 (38 mg, 0.23 mmol), 
ammonium acetate (888 mg, 11.2 mmol ) and 3-hexyn-2-one (223 mg, 2.30 mmol) in 
PhMe (5 mL) was heated under reflux for 15 hours. After cooling, the mixture was 
neutralized with saturated aqueous NaHCO3 solution. The aqueous was extracted with 
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EtOAc (3 x 20 mL) and the organic extracts were combined, washed successively with 
saturated aqueous NaHCO3 solution (20 mL) and brine (20 mL), dried (MgSO4) and 
evaporated in vacuo. Purification by column chromatography on silica, eluting with 
CH2Cl2-EtOAc (1:1 v/v), gave the title compound (193 mg, 93%) as a brown oil with 
identical spectroscopic properties. 
 
 
Synthesis of ethyl-2,6-dimethyl-4-ethylpyridine-3-carboxylate. 
 
 
 
A solution of ethyl 3-aminocrotonate (150 mg, 1.16 mmol), FeCl3 (38 mg, 0.23 mmol) 
and 3-hexyn-2-one (134 mg, 1.39 mmol) in ethanol (3 mL) was irradiated at 150 °C for 
1 h in a pressure-rated glass tube (10 mL) using a CEM Discover® microwave 
synthesizer (initial power 200 W). After cooling in a flow of compressed air, the 
mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous layer 
was extracted with EtOAc (3 x 20 mL) and the organic extracts were combined, washed 
successively with saturated aqueous NaHCO3 solution (20 mL) and brine (20 mL), 
dried (MgSO4) and evaporated in vacuo. Purification by column chromatography on 
silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title compound (206 mg, 86%) as 
a yellow oil (Found M•+, 207.1260. C12H17NO2 [M] requires 207.1291); max (neat)/ 
cm–1 3424, 2977, 2076, 1723, 1593, 1446, 1387, 1276, 1188, 1084, 1016, 899, 865, 
733; δH (500 MHz; CD3OD)/ppm 6.86 (1H, s, H-5), 4.39 (2H, q, J = 7.0 Hz, CH2), 2.60 
(2H, q, J = 7.6 Hz, 4-CH2CH3), 2.50 (3H, s, 6-Me), 1.38 (3H, t, J = 7.0 Hz, Me), 1.20 
(3H, t, J = 7.6 Hz, CH2Me); δC (125 MHz; CD3OD)/ppm 168.9 (C=O), 158.4 (C), 154.3 
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(C), 150.6 (C), 126.2 (C), 120.2 (CH), 61.1 (CH2), 26.2 (CH2), 24.2 (Me), 22.7 (Me), 
14.5 (Me) 14.1 (Me); m/z (EI) 207 (M•+, 55%), 162 (100), 161 (50). 
 
 
 
 
Synthesis of ethyl-2,6-dimethyl-4-phenylpyridine-3-carboxylate. 
 
 
 
A solution of ethyl 3-aminocrotonate (150 mg, 1.16 mmol), FeCl3 (38 mg, 0.23 mmol) 
and 4-phenyl-3-butyn-2-one (167 mg, 1.16 mmol) in ethanol (3 mL) was irradiated at 
150 °C for 1 h in a pressure-rated glass tube (10 mL) using a CEM Discover® 
microwave synthesizer (initial power 200 W). After cooling in a flow of compressed 
air, the mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous 
layer was extracted with EtOAc (3 x 20 mL) and the organic extracts were combined, 
washed successively with saturated aqueous NaHCO3 solution (20 mL) and brine (20 
mL), dried (MgSO4) and evaporated in vacuo. Purification by column chromatography 
on silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title compound (245 mg, 84%) 
as a yellow oil (Found M•+, 255.1259. C16H17NO2 [M] requires 255.1261); max 
(neat)/cm–1 3060, 2985, 2164, 1721, 1587, 1445, 1262, 1135, 1079, 970, 858, 766, 699; 
δH (500 MHz; CD3OD)/ppm 7.29 (5H, s, Ph), 6.93 (1H, s, H-5), 4.01 (2H, q, J = 7.0 
Hz, CH2), 2.55 (3H, s, Me), 2.49 (3H, s, Me), 0.90 (3H, t, J = 7.0 Hz, Me); δC (125 
MHz; CD3OD)/ppm 168.8 (C=O), 158.5 (C), 154.9 (C), 148.4 (CH), 138.7 (C), 128.3 
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(C), 128.2 (CH), 125.7 (C), 120.9 (CH), 77.2 (CH2), 61.1 (CH), 24.3 (Me), 22.7 (Me), 
13.5 (Me); m/z (EI) 255 (M•+, 45%), 211 (10), 210 (100), 209 (15). 
 
 
 
Synthesis of 2,6-dimethylpyridine-3-carbonitrite. 
 
 
 
A solution of ethyl 3-aminocrotononitrile (150 mg, 1.83 mmol), FeCl3 (60 mg, 0.36 
mmol) and 3-butyn-2-one (124 mg, 1.83 mmol) in ethanol (3 mL) was irradiated at 150 
°C for 1 h in a pressure-rated glass tube (10 mL) using a CEM Discover® microwave 
synthesizer (initial power 200 W). After cooling in a flow of compressed air, the 
mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous layer 
was extracted with EtOAc (3 x 20 mL) and the organic extracts were combined, washed 
successively with saturated aqueous NaHCO3 solution (20 mL) and brine (20 mL), 
dried (MgSO4) and evaporated in vacuo. Purification by column chromatography on 
silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title compound (202 mg, 84%) as 
a yellow oil (Found: MH+, 132.0687. C8H8N2 requires [M] 132.0687); max (neat)/cm-1  
3399, 2925, 2198, 1688, 1587, 1435, 1358, 1250, 1159, 972, 799, 735; δH (500 MHz; 
CD3OD)/ppm 7.87 (1H, d, J = 8.0 Hz, H-5), 6.49 (1H, d, J = 8.0 Hz, H-4), 2.52 (3H, s, 
Me), 2.39 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 198.6 (C), 164.1 (C), 158.5 (C), 
112.1 (CN), 110.9 (C), 26.9 (Me), 24.7 (Me); m/z (EI) 132 (M•+, 100%), 131 (10). 
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Synthesis of ethyl-2-methyl-6-phenylpyridine-3-carboxylate. 
 
 
 
A solution of ethyl 3-aminocrotonate (149 mg, 1.53 mmol), FeCl3 (48 mg, 0.3 mmol) 
and 1-phenyl-2-propyn-1-one (150 mg, 1.53 mmol) in ethanol (3 mL) was irradiated at 
150 °C for 1 h in a pressure-rated glass tube (10 mL) using a CEM Discover® 
microwave synthesizer (initial power 200 W). After cooling in a flow of compressed 
air, the mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous 
layer was extracted with EtOAc (3 x 20 mL) and the organic extracts were combined, 
washed successively with saturated aqueous NaHCO3 solution (20 mL) and brine (20 
mL), dried (MgSO4) and evaporated in vacuo. Purification by column chromatography 
on silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title compound (90 mg, 25%) 
as a orange oil; max (neat)/cm–1 3069, 2980, 1716, 1581, 1447, 1262, 1089, 976, 848, 
755; δH (500 MHz; CD3OD)/ppm 8.23 (1H, d, J = 7.0 Hz, CH), 8.05 (1H, d, J = 7.0 Hz, 
CH), 7.46 (5H, s, Ph), 4.38 (2H, q, J = 7.0 Hz, CH2), 2.66 (3H, s, Me), 1.4 (3H, t, J = 
7.1 Hz, Me); δC (125 MHz; CD3OD)/ppm 166.6 (C=O), 159.8 (C), 158.9 (C), 139.2 
(C), 138.4 (CH), 129.6 (CH), 128.7 (CH), 127.3 (CH), 123.6 (C), 117.2 (CH), 61.1 
(CH2), 25.2 (Me), 14.3 (Me); m/z (EI) 241 (M
•+, 100%), 213 (15), 196 (80), 195 (20). 
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Synthesis of 2-methyl-6-phenylpyridine-3-carbonitrile. 
 
 
 
A solution of ethyl 3-aminocrotononitrile (126 mg, 1.53 mmol), FeCl3 (48 mg, 0.3 
mmol) and 1-phenyl-2-propyn-1-one (150 mg, 1.53 mmol) in ethanol (3 mL) was 
irradiated at 150 °C for 1 h in a pressure-rated glass tube (10 mL) using a CEM 
Discover® microwave synthesizer (initial power 200 W). After cooling in a flow of 
compressed air, the mixture was neutralized with saturated aqueous NaHCO3 solution. 
The aqueous layer was extracted with EtOAc (3 x 20 mL) and the organic extracts were 
combined, washed successively with saturated aqueous NaHCO3 solution (20 mL) and 
brine (20 mL), dried (MgSO4) and evaporated in vacuo. Purification by column 
chromatography on silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title 
compound (285 mg, 95%) as an orange oil (Found M•+, 195.0915. C13H11N2 [M] 
requires 195.0917); max (neat)/cm–1 3340, 2222, 2195, 1717, 1638, 1557, 1284, 976, 
848, 739; δH (500 MHz; CD3OD)/ppm 8.04 (1H, d, J = 7.0 Hz, CH), 7.91 (1H, d, J = 
7.0 Hz, CH), 7.64 (1H, d, J = 7.0 Hz, CH), 7.49 (5H, s, Ph), 2.83 (3H, s, Me); δC (125 
MHz; CD3OD)/ppm 161.6 (C), 159.7 (C), 140.6 (C), 137.6 (C), 130.3 (C), 128.9 (CH), 
127.4 (CH), 117.3 (CN), 106.9 (CH), 76.9 (CH), 74.6 (CH), 23.9 (Me); m/z (EI) 194 
(M•+, 100%), 193 (35), 192 (10). 
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Synthesis of 2,6-dimethyl-4-ethylpyridine-3-carbonitrile. 
 
 
 
A solution of ethyl 3-aminocrotononitrile (150 mg, 1.83 mmol), FeCl3 (60 mg, 0.36 
mmol) and 3-hexyn-2-one (175 mg, 1.83 mmol) in ethanol (3 mL) was irradiated at 150 
°C (initial power 200 W) for 1 h in a sealed pressure-rated reaction tube (10 mL) using 
a CEM Discover® Microwave Synthesizer. After cooling in a flow of compressed air, 
the mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous 
layer was extracted with EtOAc (3 x 20 mL) and the organic extracts were combined, 
washed successively with saturated aqueous NaHCO3 solution (20 mL) and brine (20 
mL), dried (MgSO4) and evaporated in vacuo. Purification by column chromatography 
on silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title compound (67 mg, 24%) 
as brown oil; max (neat)/cm–1 3424, 2977, 2190, 1561, 1430, 1250, 1188, 964, 834; δH 
(500 MHz; CD3OD)/ppm 6.88 (1H, s, H-5), 2.65 (2H, q, J = 7.6 Hz, 4-CH2CH3), 2.50 
(3H, s, 6-Me), 2.15 (3H, s, Me), 1.20 (3H, t, J = 7.6 Hz, CH2Me); δC (125 MHz; 
CD3OD)/ppm 158.4 (C), 154.3 (C), 150.6 (C), 126.2 (C), 120.2 (CH), 118.7 (CN), 
26.2 (CH2), 24.2 (Me), 22.7 (Me), 14.5 (Me). 
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Synthesis of 2,6-dimethyl-4-phenylpyridine-3-carbonitrile. 
 
 
 
A solution of ethyl 3-aminocrotononitrile (150 mg, 1.83 mmol), FeCl3 (60 mg, 0.36 
mmol) and 4-phenyl-3-butyn-2-one (0.26 mL, 1.83 mmol) in ethanol (3 mL) was 
irradiated at 150 °C (initial power 200 W) for 1 h in a sealed pressure-rated reaction 
tube (10 mL) using a CEM Discover® Microwave Synthesizer. After cooling in a flow 
of compressed air, the mixture was neutralized with saturated aqueous NaHCO3 
solution. The aqueous layer was extracted with EtOAc (3 x 20 mL) and the organic 
extracts were combined, washed successively with saturated aqueous NaHCO3 solution 
(20 mL) and brine (20 mL), dried (MgSO4) and evaporated in vacuo. Purification by 
column chromatography on silica, eluting with CH2Cl2-EtOAc (1:1 v/v), gave the title 
compound (124 mg, 33%) as brown oil (Found M•+, 208.1040. C14H12N2 [M] requires 
208.1048); max (neat)/cm–1 2963, 2290, 1601, 1570, 1310, 1250, 1117, 1030, 962, 803; 
δH (500 MHz; CD3OD)/ppm 7.48 (2H, m, H-2´/H-6´), 7.48 (1H, m, H-4´), 7.31 (2H, m, 
H-3´/H-5´), 5.98 (1H, s, H-5), 2.50 (3H, s, Me), 2.17 ( 3H, s, Me); δC (125 MHz; 
CD3OD)/ppm 159.5 (C), 159.1 (C), 150.6 (CH), 139.2 (C), 128.9 (CH), 128.2 (C), 
126.1 (C), 117.8 (CN), 106.9 (CH), 74.6 (CH), 23.9 (Me), 23.2 (Me), ; m/z (EI) 208 
(M•+, 100%). 
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Synthesis of 1,3,7-trimethylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
 
 
 
A solution of 6-amino-1,3-dimethyluracil (263 mg, 1.70 mmol) and 3-butyn-2-one (115 
mg, 1.70 mmol) in acetic acid (4 mL) was irradiated at 120 °C for 30 min in a pressure-
rated glass tube (10 mL) using a CEM Discover® microwave synthesizer by moderating 
the initial power (150 W). After cooling in a flow of compressed air, the mixture was 
neutralized with saturated aqueous NaHCO3 solution. The aqueous layer was extracted 
with EtOAc (3 × 35 mL) and the organic extracts were combined, washed successively 
with water and brine, dried (MgSO4) and evaporated in vacuo to give the title compound 
(264 mg, 76%) as a creamy solid (Found [M-Me]•+, 190.0614. C10H11N3O2 [M-Me] 
requires 190.0617); max (neat)/cm–1 1660, 1500; δH (500 MHz; CD3OD)/ppm 8.32 (1H, 
d, J = 8.1 Hz, H-5), 7.03 (1H, d, J = 8.1 Hz, H-6), 3.75 (3H, s, Me), 3.45 (3H, s, Me), 
2.82 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 162.1 (C), 161.9 (C), 159.2 (C), 149.5 
(C), 138.3 (CH), 119.5 (CH), 107.5 (C), 30.1 (Me), 29.1 (Me), 26.3 (Me); m/z (EI) 191 
(MH+, 13%), 190 (M •+, 100%), 164 (33), 163 (46), 110 (7), 85 (73). 
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Synthesis of 1,3-dimethyl-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
 
 
A solution of 6-amino-1,3-dimethyluracil (120 mg, 0.77 mmol) and 1-phenyl-2-
propyn-1-one (100 mg, 0.77 mmol) in acetic acid (4 mL) was irradiated at 120 °C for 
30 min in a pressure-rated glass tube (10 mL) using a CEM Discover® microwave 
synthesizer by moderating the initial power (150 W). After cooling in a flow of 
compressed air, the mixture was neutralized with saturated aqueous NaHCO3 solution. 
The aqueous layer was extracted with EtOAc (3 × 35 mL) and the organic extracts were 
combined, washed successively with water and brine, dried (MgSO4) and evaporated 
in vacuo to give the title compound (200 mg, 98%) as a colourless solid, mp >300 °C; 
(Found M•+, 267.1008. C15H13N3O2 [M] requires 267.1008); max (neat)/cm–1 1668, 
1592, 1524; δH (500 MHz; CD3OD)/ppm 8.40 (1H, d, J = 8.1 Hz, H-5), 8.21 (2H, d, J 
= 7.5 Hz, H-2/H-6 of Ph), 7.91 (1H, d, J = 8.1 Hz, H-6), 7.55 (3H, m, H-3/H-4/H-5 of 
Ph), 3.75 (3H, s, Me), 3.45 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 160.2 (C), 150.9 
(C), 150.6 (C), 145.7 (C), 138.3 (CH), 137.8 (C), 131.0 (CH), 129.8 (CH), 128.0 (CH), 
113.7 (CH), 109.5 (C), 29.5 (Me), 28.2 (Me); m/z (EI) 268 (MH+, 14%), 267 (M•+, 100), 
226 (39), 165 (52), 77 (80). 
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Synthesis of 1,7-dimethylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
 
 
A solution of 6-amino-1-methyluracil (240 mg, 1.70 mmol) and 3-butyn-2-one (115 
mg, 1.70 mmol) in acetic acid (4 mL) was irradiated at 120 °C for 30 min in a pressure-
rated glass tube (10 mL) using a CEM Discover® microwave synthesizer by moderating 
the initial power (150 W). After cooling in a flow of compressed air, the mixture was 
neutralized with saturated aqueous NaHCO3 solution. The aqueous layer was extracted 
with EtOAc (3 × 35 mL) and the organic extracts were combined, washed successively 
with water and brine, dried (MgSO4) and evaporated in vacuo to give the title compound 
(320 mg, 99%) as an orange solid (Found M•+, 191.1008. C9H9N3O2 [M] requires 
191.1007); max (neat)/cm–1 1660, 1590, 1522, 970, 880, 723; δH (500 MHz; 
CD3OD)/ppm 8.33 (1H, d, J = 8.1 Hz, H-5), 7.08 (1H, d, J = 8.1 Hz, H-6), 3.68 (3H, s, 
Me), 3.64 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 160.1 (C), 159.8 (C), 148.5 (C), 
145.5 (C), 137.3 (CH), 117.5 (CH), 107.5 (C), 29.1 (Me), 26.3 (Me); m/z (EI) 191 (M•+, 
15%), 190 (100). 
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Synthesis of 1-methyl-7-phenylpyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione. 
 
 
A solution of 6-amino-1-methyluracil (83 mg, 0.59 mmol) and 1-phenyl-2-propyn-1-
one (77 mg, 0.59 mmol) in acetic acid (4 mL) was irradiated at 120 °C for 30 min in a 
pressure-rated glass tube (10 mL) using a CEM Discover® microwave synthesizer by 
moderating the initial power (150 W). After cooling in a flow of compressed air, the 
mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous layer 
was extracted with EtOAc (3 × 35 mL) and the organic extracts were combined, washed 
successively with water and brine, dried (MgSO4) and evaporated in vacuo to give the 
title compound (120 mg, 80%) as a yellow solid (Found M•+, 253.1008. C14H11N3O2 
[M] requires 253.1007); max (neat)/cm–1 1678, 1592, 1424, 950, 882, 723; δH (500 
MHz; CD3OD)/ppm 8.38 (1H, d, J = 7.1 Hz, H-5), 8.23 (2H, d, J = 7.5 Hz, H-2/H-6 of 
Ph), 8.09 (1H, d, J = 7.1 Hz, H-6), 7.55 (3H, m, H-3/H-4/H-5 of Ph), 3.45 (3H, s, Me); 
δC (125 MHz; CD3OD)/ppm 169.3 (C), 150.5 (C), 149.6 (C), 145.7 (C), 138.3 (CH), 
137.8 (C), 131.0 (CH), 129.8 (CH), 128.0 (CH), 113.7 (CH), 109.5 (C), 28.2 (Me); m/z 
(EI) 253 (M•+, 20%), 252 (100), 226 (30). 
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Synthesis of 2-amino-7-methylpyrido[2,3-d]pyrimidin-4(3H)-one. 
 
 
 
A solution of 2,6-diamino-4-hydroxypyridine (214 mg, 1.70 mmol) and 3-butyn-2-one 
(115 mg, 1.70 mmol) in acetic acid (4 mL) was irradiated at 120 °C for 30 min in a 
pressure-rated glass tube (10 mL) using a CEM Discover® microwave synthesizer by 
moderating the initial power (150 W). After cooling in a flow of compressed air, the 
mixture was neutralized with saturated aqueous NaHCO3 solution. The aqueous layer 
was extracted with EtOAc (3 × 35 mL) and the organic extracts were combined, washed 
successively with water and brine, dried (MgSO4) and evaporated in vacuo to give the 
title compound (263 mg, 90%) as a colourless solid, mp >300 °C; (Found MH+, 
177.0773. C8H9N4O [MH] requires 177.0776); max (neat)/cm–1 3248, 1666, 1581, 975, 
883, 720; δH (500 MHz; CD3OD)/ppm 9.05 (1H, d, J = 8.1 Hz, H-5), 7.62 (1H, d, J = 
8.1 Hz, H-6), 3.04 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 161.6 (C), 156.4 (CH), 
154.5 (C), 147.3 (C), 127.5 (CH), 121.8 (C), 113.4 (C), 20.6 (Me); m/z (EI) 177 (M•+, 
100%). 
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6.4. General procedure for H/D exchange of 4-aminopyridines under 
neutral conditions 
A solution of the substrate in D2O (5 mL) was irradiated in a sealed Pyrex tube at 190 
°C for 2 h (hold-time) using a CEM Explorer® microwave synthesizer (maximum 
pressure 150 psi) by moderation of the initial microwave power (300 W). The mixture 
was cooled in a stream of compressed air and extracted with CH2Cl2 (3 × 10 mL). The 
organic extracts were combined, dried (MgSO4), filtered and evaporated in vacuo to 
give the title compound. 
 
6.5. General procedure for H/D exchange of 4-aminopyridines in the 
presence of DCl 
A solution of the substrate in D2O (5 mL) in the presence of DCl (0.9 mL) was irradiated 
in a sealed Pyrex tube at 190 °C for 2 h (hold-time) using a CEM Explorer® microwave 
synthesizer (maximum pressure 150 psi) by moderation of the initial microwave power 
(300 W). The mixture was cooled in a stream of compressed air, neutralized by the 
addition of aqueous NaOH solution (1M; 10 mL) and extracted with CH2Cl2 (3 x 10 
mL). The organic extracts were combined, dried (MgSO4), filtered and evaporated in 
vacuo to give the title compound. 
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6.6. General procedure for determination of %D incorporation by 
acetylation. 
The deuterated isotopologue was dissolved in acetone (20 mL) and K2CO3 (5 equiv.) 
was added, followed by the dropwise addition of a solution of acetyl chloride (3 equiv.) 
in acetone (5 mL). The reaction mixture was stirred for 3 h, quenched by the addition 
of water, evaporated in vacuo and extracted with CH2Cl2 (3 times). The organic extracts 
were combined, dried (Na2SO4), filtered and evaporated in vacuo to give the  
N-acetylated derivative. 
 
6.7. General procedure for determination of %D incorporation by the 
addition of an external standard. 
 
Following general procedure for H/D exchange, 1H NMR spectroscopic analysis of the 
crude product was quantified by the addition of dioxane (50 mol%) as an external 
standard. 
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H/D exchange in 4-aminopyridine under neutral conditions. 
 
 
 
4-Aminopyridine (300 mg, 3.19 mmol) was reacted according to the general procedure, 
to give deuterated isotopologues (177 mg, 57%) as a colourless solid, mp 157 ºC; max 
(neat)/ cm–1 3433, 3144, 3036, 2967, 2262, 1686, 1616, 1583, 1519, 1368, 1299, 1279, 
1005, 891, 756; δH (500 MHz; CD3OD)/ppm 7.95 (0.04H, d, J = 5.0 Hz, H-2,6), 6.55 
(1H, s, H-3,5); δC (125 MHz; CD3OD)/ppm 155.3 (C-N), 148.4 (CH*), 148.1 (tD, J = 
26 Hz, CD), 108.9 (CH); m/z (EI) 96 (M•+, 100%), 69 (25), 41 (35).  
*Resonance due to H isotopologue 
 
H/D exchange in 4-aminopyridine in the presence of DCl. 
 
 
 
4-Aminopyridine (300 mg, 3.19 mmol) was reacted according to the general procedure, 
to give deuterated isotopologues (174 mg, 56%) as a colourless solid, mp 157 ºC; max 
(neat)/ cm–1 3422, 3309, 3133, 2027, 1583, 1445, 1420, 1210, 970, 814, 700; δH (500 
MHz; CD3OD)/ppm 7.95 (1.82H, s, H-2,6), 6.56 (0.17H, d, J = 6.0 Hz, H-3,5); δC (125 
MHz; CD3OD)/ppm 155.4 (s, C-N), 148.2 (s, CH), 108.9 (s, CH*), 108.7 (tD, J = 25 
Hz, CD); m/z (EI) 96 (M•+, 100%), 69 (34), 41 (25).  
*Resonance due to H isotopologue 
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H/D exchange in 4-(methylamino)pyridine under neutral conditions. 
 
 
 
4-(Methylamino)pyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (280 mg, 91%) as a colourless solid, mp 
125 ºC; max (neat)/ cm–1 3396, 3323, 3269, 3030, 2497, 2402, 2232, 1909, 1635, 1564, 
1460, 1301, 1250, 1153, 1042, 914; δH (500 MHz; CD3OD)/ppm 7.99 (0.04H, d, J = 
7.0 Hz, H-2,6), 6.51 (1.56H, s, H-3,5), 2.80 (3H, s, Me). δC (125 MHz; CD3OD)/ppm 
155.5 (C-N), 147.9 (tD, J = 27 Hz, CD), 106.7 (CH), 27.8 (Me); m/z (EI) 111 (52), 110 
(M•+, 100%), 109 (69). 
 
H/D exchange in 4-(methylamino)pyridine in the presence of DCl. 
 
 
 
4-(Methylamino)pyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (250 mg, 82%) as a colourless solid, mp 
125 ºC; max (neat)/ cm–1 3395, 3320, 3267, 3030, 2497, 2402, 2232, 1909, 1635, 1564, 
1460, 1303, 1250, 1153, 1040, 914; δH (500 MHz; CD3OD)/ppm 7.96 (2H, s, H-2,6), 
6.44 (0.09H, d, J = 6.0 Hz, H-3,5), 2.71 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 155.5 
(C-N), 148.1 (CH), 106.5 (tD, J = 25 Hz, CD), 27.8 (Me); m/z (EI) 110 (M
•+, 100%), 
109 (98), 108 (15), 80 (16), 53 (16). 
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H/D exchange in 4-(dimethylamino)pyridine under neutral conditions. 
 
 
 
4-(Dimethylamino)pyridine (300 mg, 2.45 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (296 mg, 97%) as a colourless solid, mp 
113-114 ºC (Found MH+, 125.1042. C7H8D2N2 [MH] requires 125.1043); max (neat)/ 
cm–1 3286, 3250, 3179, 3045, 2922, 2819, 2236, 1579, 1498, 1350, 1308, 1225, 1068, 
993, 750; δH (500 MHz; CD3OD)/ppm 8.06 (0.07H, m, H-2,6), 6.63 (1.88H, s, H-3,5), 
3.03 (6H, s, Me); δC (125 MHz; CD3OD)/ppm 155.0 (C-N), 147.7 (tD, J = 25 Hz, CD), 
106.3 (CH), 37.7 (Me); m/z (EI) 124 (M•+, 86%), 123 (100), 107 (6), 96 (24), 80 (54), 
52 (81), 42 (42). 
 
 
H/D exchange in 4-pyrrolidinopyridine under neutral conditions. 
 
 
 
4-Pyrrolidinopyridine (300 mg, 2.02 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (293 mg, 96%) as a colourless solid, mp 
59 ºC (Found MH+, 151.1199. C9H10D2N2 [MH] requires 151.1199); max (neat)/cm–1 
3074, 2961, 2910, 2845, 2230, 1583, 1532, 1478, 1361, 1286, 1246, 1154, 997, 700; 
δH (500 MHz; CDCl3)/ppm 8.20 (0.10H, d, J = 5.0 Hz, H-2,6), 6.36 (1.82H, s, H-3,5), 
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3.29 (4H, t, J = 6.0 Hz, H-2′,5′), 2.02 (4H, t, J = 6.0 Hz, H-3′,4′); δC (125 MHz; 
CD3OD)/ppm 152.4 (C-N), 147.5 (tD, J = 27 Hz, CD), 106.7 (CH), 46.7 (CH2), 24.8 
(CH2); m/z (EI) 150 (M
•+, 85%), 149 (100), 121 (15). 
 
 
 
H/D exchange in 4-pyrrolidinopyridine in the presence of DCl. 
 
 
 
4-Pyrrolidinopyridine (300 mg, 2.02 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (294 mg, 97%) as a colourless solid, mp 
59 ºC (Found MH+, 151.1199. C9H10D2N2 [MH] requires 151.1199); max (neat)/cm–1 
3012, 2961, 2918, 2897, 2845, 2297, 1585, 1535, 1455, 1387, 1306, 1285, 1194, 1174, 
915, 751; δH (500 MHz; CDCl3)/ppm 8.20 (2H, s, H-2,6), 6.36 (0.52H, d, J = 6.0 Hz, 
H-3,5), 3.29 (4H, t, J = 6.0 Hz, H-2′,5′), 2.02 (4H, t, J = 6.0 Hz, H-3′,4′); δC (125 MHz; 
CD3OD)/ppm 149.2 (C-N), 147.5 (CH), 106.8 (CH*), 106.6 (tD, J = 26 Hz, CD), 46.6 
(CH2), 24.8 (CH2); m/z (EI) 150 (M
•+, 68%), 149 (100), 148 (50), 121 (15). 
*Resonance due to H isotopologue 
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H/D exchange in 4-aminoquinoline under neutral conditions. 
 
 
 
4-Aminoquinoline (110 mg, 0.76 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (77 mg, 69%) as an orange solid, mp 155 
ºC (Found MH+, 146.0824. C9H7DN2 [MH] requires 146.0823); max (neat)/cm–1 3443, 
2968, 1683, 1528, 1475, 1339, 1316, 1245, 1009, 917, 751; δH (500 MHz; 
CD3OD)/ppm 8.25 (0.11H, s, 2-H), 8.06 (0.91H, d, J = 8.0 Hz, H-5 or H-8), 7.81 
(0.91H, d, J = 8.0 Hz, H-5 or H-8), 7.64 (1H, t, J = 8.0 Hz, H-6 or H-7) 7.43 (1H, t, J 
= 8.0 Hz, H-6 or H-7), 6.62 (0.77H, s, H-3); δC (125 MHz; CD3OD)/ppm 152.6 (C-N), 
149.2 (tD, J = 26 Hz, CD), 147.9 (C-N), 129.2 (CH), 127.4 (CH), 124.0 (CH), 121.4 
(CH), 118.6 (C), 102.2 (CH); m/z (EI) 145 (M•+, 100%), 144 (15), 118 (13). 
 
 
H/D exchange in 4-aminoquinoline in the presence of DCl. 
 
 
 
4-Aminoquinoline (200 mg, 1.38 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (150 mg, 74%) as an orange solid, mp 155 
ºC (Found MH+, 146.0824. C9H7DN2 [MH] requires 146.0823); max (neat)/cm–1 3443, 
2968, 1683, 1528, 1475, 1339, 1316, 1245, 1009, 917, 751; δH (500 MHz; 
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CD3OD)/ppm 8.27 (0.81H, s, 2-H), 8.06 (0.90H, d, J = 8.0 Hz, H-5 or H-8) 7.80 
(0.90H, d, J = 8.0 Hz, H-5 or H-8), 7.63 (0.97H, t, J = 8.0 Hz, H-6 or H-7), 7.43 (0.97H, 
t, J = 8.0 Hz, H-6 or H-7); δC (125 MHz; CD3OD)/ppm 152.5 (C-N), 149.4 (CH) 148.0 
(C-N), 129.2 (CH), 127.4 (CH), 123.9 (CH), 121.4 (CH), 118.6 (C), 102.2 (tD, J = 24 
Hz, CD); m/z (EI) 145 (M•+, 100%), 144 (12), 118 (16). 
 
 
 
H/D exchange in 4-amino-3-methylpyridine under neutral conditions. 
 
 
 
4-Amino-3-methylpyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (298 mg, 97%) as a colourless solid, mp 
106 ºC (Found MH+, 255.1259. C16H17NO2 [MH] requires 255.1261); max (neat)/cm–
1 3345, 3311, 3164, 2536, 2404, 2367, 2288, 2237, 2194, 1631, 1553, 1436, 1264, 
1197, 1042, 877; δH (500 MHz; CD3OD)/ppm 7.87 (0.06H, s, H-2), 7.71 (0.07H, d, J 
= 7.0 Hz, H-6), 6.57 (0.92H, s, H-5), 2.08 (2.96H, s, Me); δC (125 MHz; CD3OD)/ppm 
153.5 (C-N), 148.3 (CH*), 146.4 (CH*), 146.1 (tD, J = 25 Hz, CD), 116.7 (C), 108.3 
(CH), 12.7 (Me); m/z (EI) 110 (M•+, 100%), 109 (33), 81 (29). 
*Resonance due to H isotopologue 
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H/D exchange in 4-amino-2-methylpyridine under neutral conditions. 
 
 
 
4-Amino-2-methylpyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (260 mg, 84%) as a colorless solid, mp 98 
ºC; max (neat)/cm–1 3324, 3065, 2911, 2848, 2366, 1638, 1602, 1559, 1495, 1345, 
1297, 1261, 985, 705; δH (500 MHz; CD3OD)/ppm 7.84 (0.04H, d, J = 6.0 Hz, H-6), 
6.43 (0.95H, d, J = 2.0 Hz, H-3), 6.39 (0.92H, d, J = 2.0 Hz, H-5), 2.27 (0.08H, m,  
H-1′); δC (125 MHz; CD3OD) 157.3 (C-N), 155.7 (C), 147.5 (tD, J = 26 Hz, CD), 108.0 
(CH), 106.6 (CH), 21.4 (sepD, J = 19 Hz, CD3); m/z (EI) 112 (M
•+, 100%), 111 (22), 
110 (11), 83 (22), 69 (23), 41 (25). 
 
 
 
H/D exchange in 4-amino-3-bromopyridine under neutral conditions. 
 
 
 
4-Amino-3-bromopyridine (300 mg, 1.73 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (250 mg, 82%) as an orange solid, mp 70 
ºC; max (neat)/cm–1 3448, 3149, 2925, 2536, 2156, 1707, 1628, 1589, 1502, 1419, 
1339, 1270, 1184, 1074, 1013, 823; δH (500 MHz; CD3OD)/ppm 8.20 (0.02H, s, H-2), 
7.90 (0.66H, d, J = 6.0 Hz, H-6), 6.70 (0.83H, d, J = 6.0 Hz, H-5); δC (125 MHz; 
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CD3OD)/ppm 152.3 (C-N), 149.6 (tD, J = 27 Hz, CD), 147.0 (CH), 109.5 (CH), 105.4 
(C); m/z (EI) 174 (M•+, 60%), 94 (30), 67 (29). 
 
H/D exchange in 4-amino-3-iodopyridine under neutral conditions. 
 
 
 
4-Amino-3-iodopyridine (300 mg, 1.36 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (283 mg, 93%) as an orange oil, mp 99 ºC; 
max (neat)/cm–1 3421, 3294, 3038, 1639, 1581, 1491, 1412, 1337, 1267, 1185, 820, 
725; δH (500 MHz; CD3OD)/ppm 8.38 (0.01H, s, H-2), 7.92 (0.25H, d, J = 6.0 Hz, H-
6), 6.68 (0.75H, s, H-5); δC (125 MHz; CD3OD)/ppm 155.4 (tD, J = 28 Hz, CD), 154.8 
(C-N), 147.7 (CH), 108.7 (CH), 79.8 (C); m/z (EI) 222 (M•+, 100%), 221 (30) 127 (15), 
95 (23), 67 (22), 40 (20). 
 
 
H/D exchange in 4-amino-2-chloropyridine under neutral conditions. 
 
 
 
4-Amino-2-chloropyridine (300 mg, 2.33 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (298 mg, 98%) as a colourless solid, mp 
96 ºC; max (neat)/cm–1 3308, 3145, 1656, 1589, 1554, 1479, 1415, 1290, 987, 826, 
721; δH (500 MHz; CD3OD)/ppm 7.72 (0.70H, d, J = 6.0 Hz, H-6), 6.54 (0.58H, d, J = 
2.0 Hz, H-3), 6.50 (0.70H, dd, J = 2.0 Hz, H-5); δC (125 MHz; CD3OD)/ppm 157.4 (C-
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N), 151.1 (C-N), 148.2 (CH), 108.3 (CH), 107.4 (CH); m/z (EI) 128 (M[C5H5
35ClN2]
•+, 
100%), 94 (15), 93 (55), 66 (31). 
 
 
H/D exchange in 4-aminopyrimidine under neutral conditions. 
 
 
 
4-Aminopyrimidine (300 mg, 3.15 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (80 mg, 26%) as a colourless solid, mp 
156 ºC; max (neat)/cm–1 3316, 3088, 2734, 2165, 1655, 1586, 1557, 1498, 1407, 1338, 
1257, 985, 836; δH (500 MHz; CD3OD)/ppm 8.30 (0.36H, s, H-2), 8.05 (0.42H, d, J = 
6.0 Hz, H-6), 6.50 (0.78H, m, H-5); δC (125 MHz; CD3OD)/ppm 163.8 (C), 157.5 
(CH), 153.8 (CH), 105.1 (CH); m/z (EI) 97 (M•+, 88%), 96 (100), 95 (33), 69 (35), 41 
(75). 
 
 
H/D exchange in 2-aminopyrazine under neutral conditions.  
 
 
 
2-Aminopyrazine (250 mg, 2.62 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (154 mg, 61%) as a colourless solid, mp 
121 ºC; max (neat)/cm–1 3327, 3134, 3059, 2709, 2350, 2165, 2026, 1645, 1583, 1480, 
1424, 1339, 1203, 1001, 864, δH (500 MHz; CD3OD)/ppm 7.92 (0.48H, s, H-3), 7.90 
(0.83H, d, J = 2.0 Hz, H-6), 7.70 (0.83H, d, J = 2.0 Hz, H-5); δC (125 MHz; 
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CD3OD)/ppm 156.1 (C-N), 141.6 (CH), 132.5 (CH), 131.4 (CH); m/z (EI) 96 (M
•+, 
82%), 95 (100), 69 (46), 68 (70), 41 (55). 
 
6.8. General procedure for H/D Exchange Using D2O and DCl 
sequentially. 
A solution of the substrate in D2O (3 mL) was irradiated in sealed Pyrex tube (10 mL) 
at 190 °C for 2 h using a CEM Discover microwave synthesizer (maximum pressure 
150 psi) by moderating the initial power (300 W). The reaction mixture was cooled in 
a stream of compressed air and a solution of DCl 1M; (0.9 mL) was added. The mixture 
was irradiated at 190 °C for 2 h by moderating the initial power (300 W). and then 
cooled in a stream of compressed air. The solution was basified to pH 12 by the addition 
of  aqueous NaOH solution (1M; 10 mL) and extracted with CH2Cl2 (3 x 10 mL). The 
organic extracts were combined, dried (MgSO4), filtered and evaporated in vacuo to 
give the title compound. 
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H/D exchange in 4-aminopyridine using both neutral and acidic conditions. 
 
 
 
4-Aminopyridine (300 mg, 3.19 mmol) was reacted according to the general procedure, 
to give deuterated isotopologues ( 177 mg, 57%) as a colourless solid. mp 157 ºC; max 
(neat)/cm–1 3433, 3143, 3036, 2966, 2262, 1686, 1615, 1582, 1519, 1369, 1298, 1279, 
1004, 890, 755; δH (500 MHz; CD3OD)/ppm 7.95 (0.12H, s, H-2,6), 6.54 (0.07H, s, H-
3,5); δC (125 MHz; CD3OD)/ppm 155.3 (C-N), 147.9 (tD, J = 27 Hz, CD), 108.5 (tD, J 
= 24 Hz, CD); m/z (EI) 98 (M•+, 100%), 97 (55), 96 (15), 71 (50), 70 (37). 
 
 
 
H/D exchange in 4-(dimethylamino)pyridine using both neutral and acidic 
conditions. 
 
 
 
4-(Dimethylamino)pyridine (300 mg, 2.45 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (227 mg, 74%) as a colourless solid, mp 
113-114 ºC; max (neat)/cm–1 3285, 3255, 3179, 3044, 2922, 2819, 2236, 1579, 1498, 
1350,1308, 1225, 1068, 990, 750; δH (500 MHz; CD3OD)/ppm 8.04 (0.10H, s, H-2,6), 
6.54 (0.10H, s, H-3,5), 2.93 (6H, s, Me); δC (125 MHz; CD3OD)/ppm 154.8 (C-N), 
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147.7 (tD, J = 25 Hz, CD), 106.1 (tD, J = 24 Hz, CD), 37.7 (Me); m/z (EI) 126 (M
•+, 
77%), 125 (100), 124 (20), 82 (17), 54 (20). 
 
 
H/D exchange in 4-pyrrolidinopyridine using both neutral and acidic conditions. 
 
 
 
4-Pyrrolidinopyridine (300 mg, 2.02 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (200 mg, 65%) as a colourless solid, mp 
59 ºC; max (neat)/cm–1 3075, 2960, 2910, 2845, 2230, 1583, 1532, 1478, 1361, 1286, 
1246, 1154, 990, 730; δH (500 MHz; CD3OD)/ppm 8.02 (0.06H, s, H-2,6), 6.44 (0.06H, 
s, H-3,5), 3.26 (4H, t, J = 6.0 Hz, H-2′,5′), 1.99 (4H, t, J = 6.0 Hz, H-3′,4′); δC (125 
MHz; CD3OD)/ppm 152.3 (C-N), 147.2 (tD, J = 26 Hz, CD), 106.5 (tD, J = 29 Hz, CD), 
46.6 (CH2), 24.8 (CH2); m/z (EI) 152 (M
•+, 80%), 151 (100), 150 (10), 123 (16), 111 
(17), 109 (13), 69 (19), 82 (19). 
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H/D exchange in 4-(methylamino)pyridine using both neutral and acidic 
conditions. 
 
 
 
4-(Methylamino)pyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (258 mg, 84%) as a colourless solid, mp 
125 ºC; max (neat)/cm–1 3395, 3322, 3266, 3030, 2490, 2402, 2232, 1909, 1635, 1564, 
1460, 1301, 1250, 1153, 1042, 914; δH (500 MHz; CD3OD)/ppm 7.96 (0.09H, s,  
H-2,6), 6.42 (0.23H, s, H-3.5), 2.70 (3H, s, Me); δC (125 MHz; CD3OD)/ppm 155.5 
(C-N), 147.8 (tD, J = 27 Hz, CD), 106.7 (CH*), 106.4 (tD, J = 24 Hz, CD), 27.9 (Me); 
m/z (EI) 112 (M•+, 95%), 111 (100) 110 (55), 109 (11). 
*Resonance due to H isotopologue 
 
 
 
 
H/D exchange in 4-aminoquinoline using both neutral and acidic conditions. 
 
 
 
4-Aminoquinoline (130 mg, 0.90 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (81 mg, 62%) as an orange solid, mp 155 
ºC; max (neat)/cm–1 3443, 2968, 1683, 1528, 1475,1339, 1316, 1245, 1009, 917, 751; 
δH (500 MHz; CD3OD)/ppm 8.27 (0.05H, s, H-2), 8.05 (1H, d, J = 8.0 Hz, H-5 or  
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H-8), 7.80 (1H, d, J = 8.0 Hz, H-5 or H-8), 7.61 (1H, t, J = 8.0 Hz, H-6 or H-7), 7.41 
(1H, t, J = 8.0 Hz, H-6 or H-7), 6.61 (0.04H, s, H-3); δC (125 MHz; CD3OD)/ppm 152.7 
(C-N), 149.2 (tD, J = 26 Hz, CD), 147.9 (CH), 129.2 (CH), 127.3 (CH), 123.9 (CH), 
121.4 (C), 118.6 (C) 102.2 (tD, J = 26 Hz, CD); m/z (EI) 146 (M
•+, 100%), 145 (23) 
144 (6). 
 
 
 
H/D exchange in 4-amino-2-chloropyridine using both neutral and acidic 
conditions. 
 
 
 
4-Amino-2-chloropyridine (18) (300 mg, 2.33 mmol) was reacted according to the 
general procedure, to give deuterated isotopologues (278 mg, 92%) as a colourless 
solid, mp 96 ºC; max (neat)/cm–1 3322, 3140, 1655, 1589, 1544, 1479, 1415, 1290, 
987, 826, 721; δH (500 MHz; CD3OD)/ppm 7.75 (0.83H, d, J = 6.0 Hz, H-6), 6.56 
(0.02H, s, H-3), 6.50 (0.25H, d, J = 6.0 Hz, H-5); δC (125 MHz; CD3OD)/ppm 157.3 
(C-N), 151.2 (C), 148.1 (CH), 108.3 (CH*), 108.1 (tD, J = 25 Hz, CD), 107.2 (tD, J = 
25 Hz, CD); m/z (EI) 130 (M•+, 100%), 129 (40), 96 (8), 95 (60). 
*Resonance due to H isotopologue 
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H/D exchange in 4-amino-2-methylpyridine using both neutral and acidic 
conditions. 
 
 
 
4-Amino-2-methylpyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (210 mg, 67%) as a colourless solid, mp 
98 ºC; max (neat)/cm–1 3322, 3055, 2922, 2844, 2366, 1638, 1602, 1559, 1495, 1345, 
1297, 1261, 985, 750; δH (500 MHz; CD3OD)/ppm 7.83 (0.04H, d, J = 6.0 Hz, H-6), 
6.38 (0.03H, s, H-3), 6.36 (0.22H, d, J = 6.0 Hz, H-5), 2.24 (0.07H, m, H-1′); δC (125 
MHz; CD3OD)/ppm 157.3 (C-N), 155.9 (C), 147.4 (tD, J = 25 Hz, CD), 107.8 (tD, J = 
24 Hz, CD), 106.6 (CH*), 106.3 (tD, J = 25 Hz, CD), 21.4 (sepD, J = 19 Hz, CD3); m/z 
(EI) 114 (M[C6H2D6N2]
•+, 100%), 113 (42), 112 (12), 96 (8), 86 (10), 85 (15). 
*Resonance due to H isotopologue 
 
 
 
H/D exchange in 4-amino-3-methylpyridine using both neutral and acidic 
conditions. 
 
 
4-Amino-3-methylpyridine (300 mg, 2.77 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (230 mg, 75%) as a colourless solid, mp 
106 ºC; max (neat)/cm–1 3355, 3320, 3144, 2536, 2404, 2367, 2288, 2237, 2194, 1631, 
1553, 1436, 1264, 1197, 1042, 870; δH (500 MHz; CD3OD)/ppm 7.76 (0.37H, d, J = 
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6.0 Hz, H-6), 7.69 (0.04H, s, H-2),  6.57 (0.30H, d, J = 6.0 Hz, H-5), 2.04 (3H, s, Me); 
δC (125 MHz; CD3OD)/ppm 153.5 (C-N), 148.3 (CH), 147.9 (CH*), 146.3 (tD, J = 27 
Hz, CD), 116.7 (C), 108.3 (CH), 12.7 (Me); m/z (EI) 111 (M[C6H5D3N2]
•+, 78%), 110 
(100), 109 (50), 108 (17). 
*Resonance due to H isotopologue 
 
 
 
H/D exchange in 4-amino-3-bromopyridine using both neutral and acidic 
conditions. 
 
 
4-Amino-3-bromopyridine (300 mg, 1.73 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues (260 mg, 86%) as an orange solid, mp 70 
ºC; max (neat)/cm–1 3448, 3141, 2922, 2530, 2156, 1707, 1628, 1589, 1502, 1419, 
1339, 1270, 1184, 1074, 1013, 823, δH (500 MHz; CD3OD)/ppm 8.20 (0.02H, s, H-2), 
7.90 (0.74H, d, J = 6.0 Hz, H-6), 6.67 (0.90H, d, J = 6.0 Hz, H-5); δC (125 MHz; 
CD3OD)/ppm 152.2 (C-N), 149.8 (tD, J = 27 Hz, CD), 147.1 (CH), 109.5 (CH), 105.5 
(C); m/z (EI) 175 (M[C5H4DBrN2]
•+, 100%), 173 (95), 94 (45), 67 (42). 
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H/D exchange in 4-amino-3-iodopyridine using both neutral and acidic 
conditions. 
 
 
 
4-Amino-3-iodopyridine (300 mg, 1.36 mmol) was reacted according to the general 
procedure, to give deuterated isotopologues  (290 mg, 96%) as an orange oil, mp 99 
ºC; max (neat)/cm–1 3433, 3244, 3038, 1649, 1581, 1491, 1412, 1337, 1267, 1185, 820, 
725; δH (500 MHz; CD3OD)/ppm 8.36 (0.01H, s, H-2), 7.90 (0.66H, d, J = 6.0 Hz,  
H-6), 6.64 (0.82H, d, J = 6.0 Hz, H-5); δC (125 MHz; CD3OD)/ppm 155.5 (tD, J = 28 
Hz, CD), 154.7 (C-N), 147.7 (CH), 108.8 (CH), 80.2 (C); m/z (EI) 221 
(M[C5H4DN2I]
•+, 100%), 127 (5) 127 (15), 94 (35), 67 (25), 40 (18). 
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                   Inorg. Chem. 2015, 54, 5204. 
127)            Dutta, A.; Biswas, S.; Escuer, A.; Dolai, M.; Ghosh, S.; Ali, M. 
                   ChemPlusChem 2015, 80, 1440. 
128)            Maayan, G.; Christou, G. Inorg. Chem. 2011, 50, 7015−7021. 
129)            Lee, Y.; Sloane, F. T.; Blondin, G.; Abboud, K. A.; García-Serres, R.;  
                   Murray, L. J. Angew. Chem. Int. Ed. 2015, 54, 1499. 
130)            Zhao, Q.; Betley, T. A. Angew. Chem. Int. Ed. 2011, 50, 709. 
145 
 
131)            Mandal, S. K.; Roesky, H. W. Acc. Chem. Res. 2010, 43, 248. 
132)            Ritleng, V.; Chetcuti, M. J. Chem. Rev. 2007, 107, 797. 
133)            Veits, G. K.; Read deAlaniz, J. Tetrahedron 2012, 68, 2015. 
134)            Sarva, S.; Harinath, J. S.; Sthanikam, S. P.; Ethiraj, S.; Vaithiyalingam,  
                   M.; Cirandur, S. R. Chin. Chem. Lett. 2016, 27, 16. 
135)            Jamsheena, V.; Shilpa, G.; Saranya, J.; Harry, N. A.; Lankalapalli, R. S.;  
                    Priya, S. Chem. Biol. Interact. 2016, 247, 11. 
136)            Griffiths, K.; Kumar, P.; Akien, G. R.; Chilton, N. F.; Abdul-Sada, A.;  
                    Tizzard, G. J.; Coles, S. J.; Kostakis, G. E. Chem. Commun. 2016, 52, 
                    7866. 
137)            (a) Hopkins, F. G. Nature 1889, 40, 335; (b) Idem Nature 1891, 45, 197;  
                   (c) Idem Nature 1892, 45, 581. 
138)            Grivsky, E. M.; Lee, S.; Sigel, C. W.; Duch. D. S.; Nichol, C. A. J. Med. 
                   Chem. 1980, 23, 327. 
139)            (a) Matsumoto, J.; Minami, S. J. Med. Chem. 1975, 18, 74; (b)  
                    Suzuki, N. Chem. Pharm. Bull. 1980, 28, 761; (c) Oakes, V.; Rydon,  
                    H. N. J. Chem. Soc. 1956, 4433; (d) DeGraw, J. I.; Kisliuk, R. L.;  
                    Gaumont, Y.; Baugh, C. M. J. Med. Chem. 1974, 17, 470; (e)  
                    Zakharov, A. V.; Gavrilov, M. Yu.; Novoselova, G. N.; Vakhrin, M. I.; 
                    Konxhin, M. E. Khim–Farm. Zh. 1996, 30, 39. 
140)            Deyanov, A. B.; Niyazov, R. K.; Nazmetdinov, F. Y.; Syropvatov, B. Y.; 
                   Kolla, V. E.; Konshin, M. E. Khim–Farm, Zh. 1991, 25, 26. 
141)           Heckler, R. E.; Jourdan, G. P. Eur. Chem. 1991, 114, 71630. 
142)           Bagley, M. C.; Dale, J. W.; Hughes, D. D.; Ohnesorge, M.; Phillips, N. G.; 
                   Bower, J. Synlett 2001, 1523.            
143)            Bagley, M. C.; Hughes, D. D.; Lloyd, R.; Powers, V. E. C. Tetrahedron  
                   Lett. 2001, 42, 6585. 
144)           Baashen, M. A.; PhD Thesis 2013, University of Sussex. 
145)           Hughes, D. D.; Bagley, M. C. Synlett 2002, 1332. 
146)           Fischer, M.; Troschütz, R. Synthesis 2003, 1603. 
147)           Bagley, M. C.; Lin, Z.; Pope, S. J. A. Tetrahedron Lett. 2009, 50, 6818. 
148)           Bagley, M. C.; Hughes, D. D.; Lubinu, M. C.; Merritt, E. A.; Taylor, P.  
                  H.; Tomkinson, N. C. O. QSAR Comb. Sci. 2004, 23, 859. 
149)          Bagley, M. C.; Hughes, D. D.; Taylor, P. H. Synlett 2003, 259. 
146 
 
150)          McElvain, S. M.; Tate, B. E. J. Am. Chem. Soc. 1951, 73, 2760. 
151)          Roth, B.; Smith, Jr., J. M. J. Am. Chem. Soc. 1949, 71, 616. 
152)          Morgentin, R.; Jung, F.; Lamorlette, M.; Maudet, M.; Ménard, M.; Plé, P.; 
                 Pasquet, G.; Renaud, F. Tetrahedron 2009, 65, 757. 
153)          Kobayashi, T.; Inoue, T.; Kita, Z.; Yoshiya, H.; Nishino, S.; Oizumi, K.;  
                 Kimura, T. Chem. Pharm. Bull. 1995, 43, 788. 
154)          R. Morgentin, F. Jung, M. Lamorlette, M. Maudet, M. Menard, P. Ple, G. 
                 Pasduet, F. Renaud, Tetrahedron, 2009, 65, 757. 
155)          Bagley, M. C.; Temple, S. A. Unpublished results. 
156)          Notman, N. Chemistry  World 2016, 13 (7), 48. 
157)          Junk, T.; Catallo, W. J. Chem. Soc. Rev. 1997, 26, 401. 
158)          Atzrodt, J.; Derdau, V.; Fey, T.; Zimmermann, J. Angew. Chem. Int. Ed.  
                  2007, 46, 7744. 
159)          Blom, K.; Schuhardt, J.; Munson, B. Anal. Chem. 1985, 57, 1986. 
160)          Lockley, W. J. S. J. Label. Compd. Radiopharm. 2007, 50, 256. 
161)          Elander, N.; Jones, J. R.; Lu, S.-Y.; Stone-Elander, S. Chem. Soc. Rev. 
                 2000, 29, 239. 
162)          Buteau, K. C. J. High Tech. L. 2009, 10, 22. 
163)          Hanson, J. R. In The Organic Chemistry of Isotopic Labelling, The Royal  
                 Society of Chemistry: Cambridge, 2011. 
164)          Thomas, A. F. In Deuterium Labeling in Organic Chemistry; Appleton- 
                  Century-Crofts Educational Div./Meredith Corp.: New York, 1972.  
165)          Murray III, A.; Williams, D. L. In Organic Synthesis with Isotopes. Part II:  
                  Organic Compounds Labeled with isotopes of the halogens, Hydrogen, 
                  Nitrogen, Oxygen, Phosphorus and Sulfur; Interscience Publishers, Inc.: 
                  New York, 1958. 
166)          Zoltewicz, J. A.; Meyer, J. D. Tetrahedron Lett. 1968, 421. 
167)          Werstiuk, N. H.; Ju, C. Can. J. Chem. 1989, 67, 5. 
168)          Turner, J. A. J. Org. Chem. 1983, 48, 3401. 
169)          Mongin, F.; Trécourt, F.; Quéguiner, G. Tetrahedron Lett.1999, 40, 5483. 
170)          Rubottom, G. M.; Evain, E. J. Tetrahedron 1990, 46, 5055. 
171)          Tetko, I. V.; Bruneau, P.; Mewes, H. W.; Rohrer, D. C.; Poda, G. I. Drug   
                  Discov. Today 2006, 700; 10.1016/j. drudis.2006.06.013. 
172)          Chu, I.; Nomeir, A. A. Curr. Drug. Metab. 2006, 467. 
147 
 
173)          Retey, J.; Smith, E. H.; Zagalak, B. Eur. J. Biochem. 1978, 437. 
174)          Marcus, D. M.; McLachlan, K. A.; Wildman, M. A.; Ehresmann, J. O.;  
                  Kletnieks, P. W.; Haw, J. F. Angew. Chem. Int. Ed. 2006, 45, 3133. 
              
175)          Eastham, G. R.; Tooze, R. P.; Kilner, M.; Foster, D. F.; Cole-Hamilton, D.  
                  J.; J. Chem. Soc., Dalton Trans 2002, 689, 1613. 
176)          Crabtree, R. H. J. Organomet. Chem. 2004, 1, 4083. 
177)          Ribas, X.; Xifra, R.; Parella, T.; Poater, A.; Sola, M.; Llobet, A. 
                 Angew. Chem. Int. Ed. 2006, 45, 2941.  
178)          Alonso, F.; Beletskaya, I. P.; Yus, M. Chem. Rev. 2002, 102, 4009.  
179)          Mutsumi, T.; Iwata, H.; Maruhashi, K.; Monguchi, Y.; Sajiki, H. 
                 Tetrahedron 2011, 67, 1158. 
180)          Guaragna, A.; Pedatella, S.; Pinto, V.; Palumbo, G. Synthesis  
                 2006, 23, 4013. 
181)          Junk, T.; Catallo, W. J. Tetrahedron Lett. 1996, 37, 3445. 
182)          Edlund, G. B. U. Acta Chem. Scand. 1971, 3625. 
183)          Berthelette, C.; Scheigetz, J. J. Labelled Compd. Radiopharm. 2004,  
                 891; 10.1002/jlcr.879. 
184)          For Zoltewicz‘s original studies, see (a) Zoltewicz, J. A.; Smith, C. L. J.  
                  Am. Chem. Soc. 1967, 89, 3358; (b) Zoltewicz, J. A.; Kauffman, G. M.;  
                 Smith, C. L. J. Am. Chem. Soc. 1968, 90, 5939; (c) Zoltewicz, J. A.;  
                 Kauffman, G. M. J. Org. Chem. 1969, 34, 1405; (d) Zoltewicz, J. A.;  
                 Helmick, L. S. J. Am. Chem. Soc. 1970, 92, 7547; (e) Zoltewicz, J. A.; 
                 Kandetzki, P. E. J. Am. Chem. Soc. 1971, 93, 6562. 
185)          Kebede, N.; Pavlik, J. W. J. Heterocyclic Chem. 1997, 34, 685. 
186)          Sullivan, J. A.; Flanagan, K. A.; Hain, H. Catal. Today 2008, 139, 154. 
187)          Guy, K. A.; Shapley, J. R. Organometallics 2009, 28, 4020. 
188)          Beringhelli, T.; Carlucci, L.; D’Alfonso, G.; Ciani, G.; Proserpio, D. M. J.  
                 Organomet. Chem. 1995, 504, 15. 
189)          Prechtl, M. H. G.; Hölscher, M.; Ben-David, Y.; Theyssen, N.; Loschen,  
                 R.; Milstein, D.; Leitner, W. Angew. Chem. Int. Ed. 2007, 46, 2269. 
190)          Eguillor, B.; Esteruelas, M. A.; García-Raboso, J.; Oliván, M.; Oñate, E. 
                 Organometallics 2009, 28, 3700. 
 
148 
 
191)          Piola, L.; Fernández-Salas, J.; Manzini, S.; Nolan, S. P. Org. Biomol.  
                 Chem. 2014, 12, 8683. 
192)          McAuley, B.; Hickey, M. J.; Kingston, L. P.; Jones, J. R.; Lockley, W. J.  
                 S.; Mather, A. N.; Spink, E.; Thompson, S. P.; Wilkinson, D. J. J. Label.  
                 Compd. Radiopharm. 2003, 46, 1191. 
193)          Esaki, H.; Ito, N.; Sakai, S.; Maegawa, T.; Monguchi, Y.; Sajiki, H.  
                 Tetrahedron 2006, 62, 10954. 
194)          Alexakis, E.; Jones, J. R.; Lockley, W. J. S. Tetrahedron Lett. 2006, 47,  
                 5025. 
195)          Wahala, K.; Rasku, S. Tetrahedron Lett. 1997, 38, 7287. 
196)          Rasku, S.; Wahala, K. Tetrahedron 2000, 56, 913. 
197)          Barlin, G. B.; Pfleiderer, W. J. Chem. Soc. B 1971, 1425.   
198)          Di Giuseppe, A.; Castarlenas, R.; Oro, L. A. C. R. Chimie 2015, 18, 713. 
 
 
 
 
 
